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resumo 
 
 
Candida albicans é o fungo patogénico mais predominante em 
humanos, causando doenças que podem variar entre ligeiras infeções de pele 
a infeções sistémicas severas em pacientes imunodeprimidos. A natureza 
patogénica deste organismo deve-se principalmente à capacidade de 
proliferação em vários locais do corpo humano e à sua capacidade de 
adaptação a mudanças drásticas no seu ambiente. Candida albicans exibe um 
sistema de tradução único, descodificando o codão de leucina CUG 
ambiguamente como leucina (3% dos codões) e serina (97%). Para tal usa um 
tRNA híbrido de serina (tRNACAG
Ser
) que é aminoacilado por duas aminoacil-
tRNA sintetases (aaRSs): leucil-tRNA sintetase (LeuRS) e seril-tRNA sintetase 
(SerRS). Trabalhos anteriores mostraram que a exposição de C. albicans a 
macrófagos, stress oxidativo, pH e antifúngicos aumenta os níveis de 
ambiguidade de 3% a 15%, sugerindo que C. albicans tem a capacidade de 
regular os níveis de erros de tradução em resposta às defesas do hospedeiro, 
antifúngicos e stress ambiental. Desta forma, a hipótese testada neste trabalho 
é a de que a variável incorporação de Leu e Ser nos codões CUG é 
dependente da competição entre LeuRS e SerRS pelo tRNACAG
Ser
. Para testar 
esta hipótese, os níveis de SerRS e LeuRS foram indiretamente quantificados 
em diferentes condições fisiológicas, usando um sistema repórter fluorescente 
que determina a atividade dos respetivos promotores. Os resultados sugerem 
que o aumento de incorporação de leucina em codões CUG está associado a 
um aumento da expressão de LeuRS, sendo mantidos os níveis de SerRS. 
Na segunda parte do trabalho, pretendeu-se identificar possíveis 
reguladores da expressão da SerRS e LeuRS. Para tal, uma coleção de 
estirpes de C. albicans com fatores de transcrição deletados foram 
transformadas com o sistema repórter fluorescente, de forma a quantificar a 
expressão das duas aaRSs. Alterações no rácio LeuRS/SerRS em estirpes 
deletadas relativamente à estirpe não deletada permitiram identificar 5 fatores 
de transcrição como possíveis reguladores da expressão destas duas aaRSs: 
ASH1, HAP2, HAP3, RTG3 e STB5. Globalmente, este trabalho constitui o 
primeiro passo para elucidar o mecanismo molecular de regulação de erros de 
tradução em C. albicans.  
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abstract 
 
Candida albicans is the major fungal pathogen in humans, causing 
diseases ranging from mild skin infections to severe systemic infections in 
immunocompromised individuals. The pathogenic nature of this organism is 
mostly due to its capacity to proliferate in numerous body sites and to its ability 
to adapt to drastic changes in the environment. Candida albicans exhibit a 
unique translational system, decoding the leucine-CUG codon ambiguously as 
leucine (3% of codons) and serine (97%) using a hybrid serine tRNA 
(tRNACAG
Ser
). This tRNACAG
Ser
 is aminoacylated by two aminoacyl tRNA 
synthetases (aaRSs): leucyl-tRNA synthetase (LeuRS) and seryl-tRNA 
synthetase (SerRS). Previous studies showed that exposure of C. albicans to 
macrophages, oxidative, pH stress and antifungals increases Leu 
misincorporation levels from 3% to 15%, suggesting that C. albicans has the 
ability to regulate mistranslation levels in response to host defenses, 
antifungals and environmental stresses. Therefore, the hypothesis tested in this 
work is that Leu and Ser misincorporation at CUG codons is dependent upon 
competition between the LeuRS and SerRS for the tRNACAG
Ser
. To test this 
hypothesis, levels of the SerRS and LeuRS were indirectly quantified under 
different physiological conditions, using a fluorescent reporter system that 
measures the activity of the respective promoters. Results suggest that an 
increase in Leu misincorporation at CUG codons is associated with an increase 
in LeuRS expression, with levels of SerRS being maintained. 
In the second part of the work, the objective was to identify putative 
regulators of SerRS and LeuRS expression. To accomplish this goal,  
C. albicans strains from a transcription factor knock-out collection were 
transformed with the fluorescent reporter system and expression of both aaRSs 
was quantified. Alterations in the LeuRS/SerRS expression of mutant strains 
compared to wild type strain allowed the identification of 5 transcription factors 
as possible regulators of expression of LeuRS and SerRS: ASH1, HAP2, 
HAP3, RTG3 and STB5. Globally, this work provides the first step to elucidate 
the molecular mechanism of regulation of mistranslation in C. albicans. 
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1. Genetic code 
 1.1.1  Standard genetic code 
In 1968, Crick defined the genetic code as a universal non-overlapping triplet code 
that translates the nucleotide sequences into amino acid sequences (1). This code consists 
of 64 codons (Figure 1.1) comprising all possible three nucleotide combinations (from a set 
of four nitrogenated bases, A, T, C and G). Sixty one of those codons encode the canonical 
20 amino acids, the building blocks of the proteins. The other three (TAG, TAA, TGA) 
lack a complementary tRNA and act as stop codons to end protein translation (2-4). Most 
amino acids, except methionine and tryptophan, are specified by more than one codon, 
showing that the genetic code is highly redundant (5, 6). For example, leucine (Leu) and 
serine (Ser) are codified by 6 different codons that are called synonymous codons.  
By the time it was established, the genetic code was hypothesized as a “frozen 
accident”, a random event that originated the strict codon-amino acid association, whose 
structure was shared by organisms across all domains of life (1, 6). However, the discovery 
of two additional amino acids (selenocysteine and pyrrolysine) and the fact that the genetic 
code is not strictly universal contradict the “frozen accident” hypothesis and its origin and 
evolution are still open to debate (5, 7, 8).  
 
 
 
 
 
 
 
 
 
 
Figure 1.1 – Standard genetic code table .  
The standard genetic code contains 64 codons of which 61 codify 20 different amino acids and 3 
codify stop codons. Adapted from Clancy and Brown, 2008.  
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 1.1.2  Genetic code alterations 
The genetic code is highly conserved among all species and it was initially 
postulated by Crick as immutable, since any change would produce altered proteins, 
leading to proteome chaos that would be lethal to the cell (1, 9). 
However, the discovery in 1979 that the stop codon UGA was decoded as 
tryptophan in human mitochondria has called the universality of the genetic code into 
question (10, 11). Since then, several genetic deviations have been found both in nuclear 
and organellar genomes (plastids and mitochondria) (12). Alterations in mitochondrial 
DNA have been described both in nonsense and sense codons in multicellular and 
unicellular eukaryotes (10, 13). For instance, the UAG codon is translated as tyrosine in 
calcareous sponges (14) but encodes leucine or alanine in some green algae (15). Arginine 
codons (AGA and AGG) have been reassigned to serine in Bilateria, to glycine in 
Urochordates and became stop codons in vertebrates (16). Also, mitochondria of the yeast 
species Saccharomyces, Nakaseomyces and Vanderwaltozyma decode the four Leu-CUN 
codons as threonine (17). 
In contrast, in prokaryotic and eukaryotic nuclear genomes only nonsense codons 
reassignments have been found and part of them are found in mitochondria (13). The 
rationalization is that mitochondrial genomes are particularly tolerant to reassignments due 
to their reduced genome size and complexity, when compared to nuclear genomes (18). 
Examples of nuclear reassignments include the UGA translation as tryptophan in 
Mycoplasma spp. and cysteine in Euplotes spp., rather than a termination codon (9). The 
genera Oxytricha, Paramecium and Tetrahymena decode UAA and UAG codons as 
glutamine (19). Also, in Bacillus subtilis the UGA stop codon is decoded as tryptophan, 
but also retained its ability to be used for translation termination (20). Currently, the only 
exception is the decoding of the leucine CUG codon as serine in six species of the genus 
Candida and Debaryomyces (10, 13). In total, there are 23 known deviations from the 
genetic code in nuclear or mitochondrial codes (Figure 1.2)(12). 
 The genetic code has also suffered an expansion from 20 to 22 amino acids in the 
last years. The 21
st
 amino acid is selenocysteine (Sec) and is incorporated in all three 
domains of life at UGA stop codons (7, 10, 21), while the 22
nd
 amino acid is pyrrolysine 
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(Pyl) and is encoded by the UAG termination codon, mostly, in the Methanosarcinaceae 
family (22). Incorporation of Sec and Pyl in response to an in-frame stop codon is achieved 
by a complex recoding machinery to inform the ribosome not to stop at this position on the 
mRNA. Combined, genetic code expansion and deviations encountered contradict the 
“frozen accident” theory and show that the genetic code may be still evolving. 
 
 
 
 
 
 
 
 
 
 
 
 
1.2  Genetic code components 
 1.2.1  tRNA 
Transfer RNAs (tRNAs) are short non-coding RNAs of approximately 70-100 
nucleotides, which principal function is to recognize the codon and transfer the cognate 
amino acid to the growing polypeptide chain in the ribosome (23). Thus, tRNAs function 
as adaptors between the decoding of the genetic information and protein synthesis (24). 
Besides this function, tRNAs are also responsible for functions such as cell wall 
biosynthesis, protein labelling for degradation, apoptosis and precursors of small 
regulatory RNAs (25, 26). 
Figure 1.2 – The standard code and its variations.  
The genetic code is shown in a circular form. Known differences to the  standard genetic code are 
represented outside of the circle, where: red stands for mitochondrial, blue for some bacteria and 
eukaryotes and orange for the ambiguous yeast nuclear code. Adapted from Lobanov et al., 
2010. 
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Canonically, tRNAs have a clover-leaf secondary structure that is divided in 4 
domains: an amino acid accepting stem (AAS) containing 7 base pairs followed by an 
unpaired nucleotide at position 73 and the 3’-CCA terminal, a D-Stem loop (DSL) with 4 
base pairs and a D-loop of 8-11 bases, an anticodon stem loop (ASL) with a 5 base pairs 
stem and a 7 nucleotide loop, a T-stem loop (TSL) containing a stem of 5 base pairs and a 
variable region of 4 to 24 nucleotides. The AAS is where the amino acid is attached and 
the DSL and TSL are named by the presence of the conserved dihydrouridine (D) and 
ribothymidine (T) residues, respectively. The ASL detains the anticodon located between 
positions 34-36 in the centre of the loop and the variable arm connects the ASL and TSL 
stems. The presence of conserved and semi-conserved residues shapes the tRNA into its 
three-dimensional L-like structure (Figure 1.3) (27, 28). 
In eukaryotes, tRNAs are transcribed as precursor molecules by RNA polymerase 
III and are submitted to a series of post-transcriptional alterations to generate mature 
tRNAs. These maturation steps occur in the nucleus and include the removal of the 5’ and 
3’ nucleotide extensions and addition of a CCA sequence to the 3’ terminal that is required 
for aminoacylation. Next, end-processed tRNAs are exported to the cytoplasm where 
introns are removed by the splicing machinery (29, 30) 
 
 
 
 
 
 
 
 
Apart from end processing and splicing, tRNA maturation also comprises a number 
of nucleotide modifications (30). In fact, tRNAs are the most modified type of RNAs. It is 
estimated that 15% to 25% of all nucleotides in eukaryotic tRNAs contain modifications. 
Figure 1.3 – Structure of tRNA. 
(A) Cloverleaf secondary structure. (B) L-shaped tRNA tertiary structure. In both figures, red is 
the aminoacyl stem; blue is the t‐stem–loop; orange is the variable loop; green is the anticodon 
stem–loop; and black is the d‐stem–loop. Adapted from Giege et al., 2012. 
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These modifications include different reactions such as deaminations, glycosylation and 
methylations. These modifications play an important role in tRNA stability, tRNA 
discrimination and translation fidelity itself (31). Particularly, alterations at the wobble 34 
position and position 37 in the anticodon loop. For instance, an anticodon with an U34 
decodes both A and G nucleotides while I34 recognizes C, A and U bases, allowing tRNAs 
to read more than one codon (32). Modifications in the position 37 facilitate the 
maintenance of the loop conformation also important for an efficient anticodon-codon base 
pairing (33, 34). tRNA changes that affect codon/anticodon base pairing or recognition by 
aaRSs are the causes of the majority of the genetic code alterations (9, 21). 
 1.2.2  aaRSs 
Aminoacyl-tRNA synthetases (aaRSs) are a family of enzymes responsible for 
charging tRNAs with their cognate amino acid, thus providing a relationship between the 
codon, anticodon and the correspondent building block of proteins (35). The attachment of 
the amino acid to its correspondent tRNA or aminoacylation occurs in two reactions. 
Firstly, the amino acid is activated with ATP at the aaRS active site generating aminoacyl-
adenylates (AA-AMPs), and secondly, the intermediate AA-AMP is transferred to the 
3’end of tRNA, releasing the AMP (Figure 1.4) (36, 37).  
In eukaryotes, there are two groups of aaRSs, 20 cytoplasmic enzymes and 20 
nuclear-encoded mitochondrial enzymes, 1 for each standard amino acid (38). 
(1) (2) 
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Figure 1.4 – Aminoacylation reaction.  
(1) The amino acid is activated with ATP at the aaRS active site to form aminoacyl adenylate 
(aa-AMP), with the release of pyrophosphate (PPi). (2) The intermediate aaAMP is then 
transferred to the tRNA 3’ end. Adapted from Ling et al., 2009 and Pang et al, 2014. 
Synthetases can be separated in two groups based on the structural differences 
between the domains (catalytic and tRNA recognition sites). Class I enzymes have an 
active-site domain that forms a Rossmann fold (five-handed parallel β-sheet) that promotes 
the aminoacylation reaction, binds the minor groove of the tRNA acceptor branch, and 
normally aminoacylates the 2’-OH group of the terminal tRNA nucleotide. In contrast, 
class II enzymes aminoacylation sites have an antiparallel β-sheet, bind the major groove 
of the tRNA acceptor stem, and aminoacylate the 3’-OH position of the terminal ribose 
(38, 39). 
 Accurate recognition of tRNAs by aaRSs is vital for the fidelity of the 
aminoacylation reaction and, consequently, to the fidelity of protein synthesis. tRNAs 
share the same secondary and tertiary structures. So, aaRS distinguish tRNAs by a set of 
domains, called identity elements (37, 40). Identity elements include the position 73 (N73) 
(tRNAs for chemically similar amino acids have the same nucleoside at position 73) and 
nucleotide variations at the anticodon loop and acceptor stem of the tRNA, regions directly 
involved with aaRSs interaction. These are grouped either as determinants, elements that 
promote aminoacylation, or anti-determinants, elements that prevent mischarging (37). 
Interesting examples of anti-determinants are the G73 nucleotide on yeast tRNA
Ser 
that 
hinders LeuRS recognition and the A73 nucleotide on tRNA
Leu 
that prevents SerRS 
recognition (37, 41). 
In addition, aaRSs possess quality control mechanisms to assure a correct match 
between the amino acid and their cognate tRNA. It is estimated that aaRSs have an error 
rate of 10
-4 
in the amino acid selection and 10
-6
 in tRNA discrimination (42). Some 
synthetases have the ability to hydrolyse AA-AMPs at the catalytic site (pretransfer 
editing), while others carry a specific editing domain to deacylate tRNAs incorrectly 
charged (posttransfer editing) or some of them use both of the editing mechanisms (42, 
43). SerRS, MetRS and class II LysRS are the only three enzymes that do not possess 
domains for posttranfer editing. So, these three aaRSs only perform pretransfer editing in 
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the catalytic site. Essentially, incorrect AA-AMPs or mischarged AA-tRNAs are 
hydrolysed by the nucleophilic attack of water to release the amino acid (42, 44).  
Although aaRSs play an important role in the translation machinery, as mentioned, 
several non-canonical functions have been discovered in the last years. Among them are 
RNA splicing, transcriptional and translational regulation through binding with 
transcription factors and involvement in signalling responses, such as apoptosis and 
inflammation (45). Considering the range of activities and uncovered protein-protein 
interactions, it is though that these synthetases are key players in the response to the 
various cellular stresses to maintain homeostasis (46). Moreover, altered expression of 
aaRSs has been associated with human disorders such as cancer, neuronal and autoimmune 
diseases (47, 48). For this reason, aaRSs are an attractive target for the development of 
therapies (49), including approaches that aim their active sites in pathogenic 
microorganisms (47). 
1.3  Translation 
 1.3.1  Mechanism of mRNA translation 
The genetic information flows from DNA to RNA to protein. Messenger RNA 
molecules (mRNAs) are produced by transcription from DNA and then are processed. In 
eukaryotic cells, mRNAs resulting from transcription are interrupted by introns that are 
removed by a splicing reaction.  Additionally, both ends of the mRNAs are modified: a 
m7G cap is added to the 5’-end and the 3’-end is polyadenylated with a poly A tail (50). 
Once the mRNAs are processed, their open reading frames (ORF) are translated into the 
amino acid sequence of a protein following the rules of the genetic code. The mRNA 
sequence is translated into an amino acid sequence until a stop codon is encountered. Then, 
the ribosome releases the finished protein (50, 51). 
Therefore, the translation cyclical process can be divided into three steps: initiation, 
elongation and termination (Figure 1.5). To initiate translation in eukaryotic mRNAS, 
besides the ribosome, at least 12 proteins are needed. They are called eukaryotic initiation 
factors (eIFs). The translation initiation phase starts with the formation of a ternary 
complex consisting of GTP, a methionyl tRNA (initiator tRNA) and the initiation factor 
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eIF2. The ternary complex and additional initiation factors associate with the ribosomal 
40S subunit to form a 43S pre-initiation complex. These factors attach to the capped 5’ end 
of the mRNA and scan the mRNA in the 3’ direction, until the AUG initiation codon is 
encountered, and pair with the initiator tRNA at the ribosomal P-site. Once it happens, the 
60S ribosomal subunit is joined to begin the polypeptide elongation (52-54). The next 
codon of the ORF is present in the A (acceptor) site of the ribosome until the binding of the 
correspondent aminoacyl-tRNA (aa-tRNA) (55). Elongation proceeds and the peptide 
chain is assembled step-by-step in accordance with the sequence of the mRNA. This phase 
is less complex than initiation, as mainly only two eukaryotic elongation factors (eEFs) are 
required: eEF1A and eEF2 (51, 54), with the exception of yeast and higher fungi that use 
an additional eEF3 (55). eEF1A helps the delivery of the charged tRNA to the ribosome, 
eEF2 promotes the movement of the tRNAs present in the A and P sites to P and E (exit) 
sites respectively, and it is thought that eEF3 may aid the release of deacylated tRNA from 
the E site (55, 56). When the ribosome encounters a stop codon, the release factor eRF1 
(eukaryotic elongation release factor 1) recognizes it, and in association with eRF3 
(eukaryotic elongation release factor 3), stimulates the release of the peptide chain and the 
ribosomal subunits (51, 54). Subunits of the ribosome dissociate, mRNA and deacylated 
tRNA are released, originating the necessary components for the next translation cycle (55, 
57). 
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Figure 1.5 – mRNA translation.  
Overview of the three stages of mRNA translation in eukaryotes: (a) initiation, (b) elongation 
and (c) termination. a) Assembly of the 43S pre-initiation complex and scan of the mRNA until 
the AUG initiation codon is encountered. b) Peptide chain elongation according with the mRNA 
sequence. c) Stop codon is recognized, activating the release of the peptide. The complex is 
dissociated and the ribosomal subunits are recycled. Adapted from Walsh and Mohr 2011.  
 1.3.2   Mistranslation 
In spite of the surveillance mechanisms, errors in protein synthesis are inevitable. It 
is estimated that during translation 1 mistake per 10
4 
codons translated is made (58). In 
eukaryotes, these errors can occur at all stages of the flow of the genetic information: 
transcription, splicing and translation. Even in cases where proteins have the correct amino 
acid sequence, post-translational modifications errors as well as folding errors may alter 
their function (Figure 1.6) (58, 59). The error frequency in protein synthesis is not fully 
understood, but evidence suggests that the translation process is the most error prone and 
that error rates are similar in prokaryotes and eukaryotes (60).  
 
Figure 1.6 – Causes of errors in protein synthesis in eukaryotes.  
Altered proteins can result from errors in different phases, such as, transcription , splicing 
mechanisms, translation, protein folding and protein modifications after the translation process. 
Adapted from Drummond and Wilke 2009.  
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Translation errors can occur during tRNA charging by aaRSs or during mRNA 
decoding by the ribosome. Mischarging errors are mainly caused by failure of the aaRSs to 
distinguish similar amino acids or by the incorrect recognition of tRNAs. These errors can 
be prevented by aaRSs editing mechanisms, which clear the incorrect bound amino acids 
and by specific tRNA-aaRS interaction (60, 61). Codon decoding errors fall into three 
categories: nonsense errors, missense errors and frameshifting. Nonsense errors occur 
when the ribosome prematurely terminates the translation of a coding sequence. Missense 
errors occur when the wrong amino acid is incorporated. Finally, frameshifting results 
from the loss of the mRNA reading frame, leading to premature termination (58, 62). 
These errors contribute to the production of misfolded proteins (58), which can be refolded 
with the aid of molecular chaperones or can be degraded through the ubiquitin-proteasome 
system. When these unfolded proteins exceed the capacity of cells to remove them, toxic 
aggregates can accumulate (63, 64). 
Normally, mistranslation is viewed as deleterious because it produces proteins with 
altered function that can reduce growth rate and fitness (59, 65). Several alterations in 
aaRSs are linked with disease, namely cancer, type 2 diabetes mellitus and neuronal 
disorders (47, 48). One good example is the mouse sticky mutation which is an alteration 
in the editing domain of alanyl-tRNA synthetase that compromises the removal of 
mischarged tRNAs, introducing genetic code ambiguity. Ultimately, it causes 
accumulation of misfolded proteins that leads to neurodegeneration (66). Following this 
discovery, it was investigated if editing defects in another aaRS (Valyl-tRNA synthetase-
ValRS) in mammalian cells would have similar consequences. It was observed that 
mutations in the editing domain of ValRS also induced an increase of amino acid 
misincorporation. Additionally, the editing alteration in ValRS is sufficient to modify cell 
morphology and initiate caspase-dependent apoptosis (67). Mutations in at least five 
different aaRS genes (namely the glycyl-tRNA synthetase gene) were found in patients 
with peripheral neuropathy Charcot-Marie-Tooth (CMT). The direct link between aaRS 
mutations and the disease remains elusive, but evidence suggests that impaired tRNA 
charging  in peripheral nerve axons may be in play (68). These investigations demonstrate 
that mistranslation in mammalian cells may be related to cell pathology. 
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 On the other hand, there is evidence that in numerous cases mistranslation 
originated altered proteins that contribute to an improved cellular stress response and 
adaptation (69, 70). It was reported that Mycoplasma spp. have editing defective LeuRS, 
PheRS (phenylalanyl-tRNA synthetase) and ThrRS (treonyl-tRNA synthetase). These 
synthetases have mutations and deletions in their editing domains, resulting in mischarging 
of the corresponding tRNAs. These mischarged tRNAs increase mistranslation and 
ultimately lead to the production of statistical proteins. The increase of mistranslation 
levels could be the source of antigenic diversity that Mycoplasma uses to escape host 
immune system (71). Another example is the mysacylation of Met to non-methionyl-
tRNAs (Met-tRNAs) in E.coli, yeast and mammalian cells, under oxidative stress. It was 
proposed that Met reacts with ROS (reactive oxygen species) produced by oxidative stress, 
protecting the proteome from oxidative damage (59, 72). In Mycobacteria, high rates of 
substitution of glutamate for glutamine and aspartate for asparagine is also beneficial. 
Misincorporation of glutamate and aspartate generate protein variants important for 
phenotypic tolerance to the antibiotic rifampicin (73). 
 The mistranslation phenomenon can also be observed in several species of the 
genus Candida, particularly in Candida albicans, where the leucine CUG codon is read by 
a tRNA (tRNACAG
Ser 
) as leucine (~3%) and serine (~97%) (74). Strains that 
misincorporate increasing levels of leucine at CUG codons show remarkable phenotypic 
diversity and have a better response to stressful conditions such as presence of metals (75), 
antifungal drugs, alteration of pH and temperature (76) and macrophage phagocytosis (77). 
Altogether, these examples indicate that genetic code alterations are not mere 
abnormalities and can, in fact, represent a potential to adaptation, allowing species to 
colonize new ecological niches. 
1.4  Candida albicans 
 1.4.1  C. albicans biology 
Candida albicans is an eukaryotic yeast of the fungal kingdom (78).  
C. albicans genome is divided in eight pairs of chromosomes, which genome size is 14.3-
14.4 Mb encoding 6,107-6,159 genes (79). For a long time, it was thought that C. albicans 
Chapter I – Introduction 
14 
 
was an obligate diploid (2N) but recently tetraploid and haploid cells have been detected 
(80).  
This fungus is an opportunistic commensal which colonizes skin, genital and/or 
intestinal mucosa of 30-70% of healthy individuals and, under normal circumstances, does 
not cause significant disease (81). However, under certain conditions such as treatment 
with antibiotics, aggressive chemotherapy, diabetes and immune suppression, C. albicans 
is capable of causing infection in the host (82). C. albicans can be responsible for a range 
of infections, from mild skin and mucosal infections to severe systemic infections in a 
number of organs (81, 83, 84). Although infections from other species of Candida have 
become more widespread, C. albicans is still the most prevalent human pathogen (85).  
Interestingly, C. albicans cells have the ability to present three different 
morphologies: yeast (blastospores) and the filamentous forms pseudohyphae and hyphae 
(Figure 1.7). Cells with unicellular yeast morphology are similar to yeast Saccharomyces 
cerevisiae. Pseudohyphal cells are in the intermediary form and consist of attached 
elongated cell buds that keep constrictions at the septa formation, while hyphal cells have a 
long shape with no visible constrictions (86, 87). This form of morphological switching 
depends upon extracellular conditions and is considered important to stress adaptation and 
virulence (88).  
Another important growth feature of C. albicans is the “white-opaque” transition.  
C. albicans can reversibly change from the normally white and domed-shaped colonies 
(containing round-shaped cells – white cells) to opaque and flat colonies (containing 
elongated cells) (86, 89). The “white-opaque” switch is one of the key regulators of mating 
in C. albicans (90). To date, no complete sexual cycle has been described in C. albicans 
although an elaborate mechanism for mating does exist. The described cycle for  
C. albicans is a parasexual cycle. In this case, mating of diploid cells is followed by 
mitosis and concerted chromosome loss instead of meiosis (91). Diploid cells (2n) of  
C. albicans are typically heterozygous at the mating type locus (MTL), MTLa and MTLα, 
but cells may lose their heterozygosity by loss of one copy of Chromosome 5, eliminating 
the a or α allele. The resulting α/α or a/a diploid strains (2n, opaque cells) undergo 
pheromone signalling between cells of opposite genotypes. When diploid a/a and α/α cells 
mate, they form tetraploid aa/αα cells (4n, white cells) which undergo mitosis and non-
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meiotic reduction in the number of chromosomes to return to diploid a/α cells (2n, white 
cells). The parasexual cycle is completed with no recognized meiosis (89, 92). Apparently, 
haploid cells are also formed via a non-meiotic reduction in chromosome number, similar 
to that seen in the tetraploid-to-diploid transition (80). The existence of semi-stable, non-
diploid C. albicans cell types highlights the flexibility of the C. albicans genome (93).  
 
 
 
 
 
 1.4.2  C. albicans genetic code 
Several Candida species, Pichia stipites, Debararyomyces hansenii and 
Lodderomyces elongisporus (species belonging to the CTG clade), have the exceptional 
capability to translate the Leu-CUG codon as serine using the tRNACAG
Ser
 in the cytoplasm 
(94). It is estimated that the reassignment process began approximately 275 million years 
ago with the appearance of the hybrid tRNACAG
Ser 
(95, 96). The tRNACAG
Ser
 was able to 
compete with the natural tRNACAG
Leu
 decoder for the CUG codon, thus generating an 
ambiguous CUG codon. This enabled CUG reassignment through selection of the mutant 
Ser-tRNA and elimination of the cognate Leu-tRNA. The Ser-tRNACAG was maintained in 
the lineage that originated the genus Candida, but was lost in the lineage leading to the 
genus Saccharomyces. This separation occurred 170 million years ago, indicating that the 
yeast ancestor was ambiguous for at least 100 million years. CUG codon ambiguity 
imposed strong negative selection against old CUG codons, which mutated to UUG and 
UUA codons and this resulted in low CUG codon usage (94). Currently in the genus 
Candida, some species still have CUG ambiguity (as in the case of C. albicans), while 
others have achieved complete reassignment of the CUG codon (such as C. cylindracea) 
(95, 96).   
Figure 1.7 – Major morphologies of candida albicans.  
A- Yeast cells (also called blastospores). B- Pseudohyphal cells. C- Hyphal cells. (Cells 
photographed at 630x magnification).  
B C A 
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In C. albicans, the CUG is ambiguously decoded as Ser (~97%) and Leu (~3%) by 
this novel tRNACAG
Ser
, which is charged by two aaRSs: SerRS (seryl-tRNA synthetase) 
and LeuRS (leucyl-tRNA synthetase) (74, 97). This dual recognition by SerRS and LeuRS 
originates two aminoacyl-tRNAs (Leu-tRNACAG
Ser
 and Ser-tRNACAG
Ser
), which insert 
either Leu or Ser at CUG sites during mRNA translation (95).  
 The hybrid nature of tRNACAG
Ser 
is due to the presence of identity elements for both 
aaRSs. For example, nucleotides A35
 
and G37
 
in the anticodon loop are directly identified 
by LeuRS. Contrarily, SerRS recognizes three G-C base pairs in the variable loop and the 
Ser-tRNA discriminator base G73. In addition, the tRNACAG
Ser 
contains a guanosine at 
position 33 (G33), located to the 5’ base of the anticodon, in substitution of the regular 
uridine (U33). Since this mutation induces a modification of the tRNACAG
Ser
 anticodon stem 
that lowers the efficiency of LeuRS binding, it is considered a key element in CUG 
reassignment (Figure 1.8). (13, 95, 98). 
 
 
 
 
 
 
  
 1.4.3  Mistranslation in C. albicans 
Considering that serine is hydrophilic, whereas leucine is hydrophobic, the variable 
incorporation of these two amino acids into a protein has the potential to create proteins 
with altered function (77, 99). Previous study from Gomes et al. demonstrated that levels 
of leucine misincorporation at the CUG codons increase in response to different growth 
Figure 1.8 – Secondary and tertiary structures of the C. albicans tRNACAG
Ser
.  
Representation of identity elements for both SerRS and LeuRS. Adapted from Miranda et 
al.,2007. 
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conditions in C. albicans: oxidative stress, temperature and pH. Cells grown at 30ºC 
presented 2.96% of Leu misincorporation, while at 37ºC the values increased to 3.9%, to 
4.03% in presence of hydrogen peroxide (H2O2) and to 4.95% at pH4. This study also 
described that there are 13,074 CUG codons distributed over 66% of C. albicans genes, 
which suggests that CUG ambiguity contributes to the expansion of the proteome and 
phenotypic diversity (74). Interestingly, the distribution of the CUG codons in the genome 
is non-random. Rocha and colleagues performed an extensive structural analysis of  
C. albicans proteins containing CUG-encoded residues (99) and revealed that 90% of the 
CUG codons are located in nonconserved positions where both leucine and serine can be 
introduced without major disruption of protein structure and function. Data was reinforced 
with the crystal structures of the two isoforms of C. albicans SerRS. Leucine or serine 
incorporation at the CUG position in C. albicans SerRS induced only local structural 
changes. Consequently, the Leu/Ser ambiguity cause minimal protein misfolding and it 
explains the tolerance of C. albicans cells to mistranslation (99).  
High tolerance to CUG ambiguity was unequivocally demonstrated by Bezerra et 
al. In this study, C. albicans strains were constructed by engineering Ser-tRNAs to 
misincorporate increasing levels of Leu at CUG codons. These recombinant strains 
tolerated levels ranging from 20% to 99% of Leu at CUG sites. Surprisingly, the 
misincorporating strains grew faster than the control strain in the presence of oxidative 
stressors (menadione and H2O2) and protein misfolding agents (guanidine hydrochloride 
and urea). In addition, ambiguous cells were more tolerant against the antifungals, 
fluconazole and itraconazole, than the control. Moreover, CUGs are prevalent in genes 
associated with membrane and cell wall processes, which suggest that CUG ambiguity 
may influence drug resistance and the way C. albicans interacts with the immune system 
(76). 
 The transcriptional response to mistranslation has been investigated by gene 
profiling in yeast. To do so, Saccharomyces cerevisiae strains were transformed with a 
plasmid containing one copy of the hybrid C. albicans tRNACAG
Ser
 (100). This 
manipulation increased mistranslation in yeast to 1.4%, which triggered up-regulation of 
genes related to oxidative and general stress, carbohydrate metabolism and molecular 
chaperones. In contrast, genes involved with the protein synthesis machinery were down-
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regulated (100, 101). This group of genes are usually included in a core transcriptional 
response to stress, known as ESR (approximately 220 genes in S. cerevisiae). These results 
showed how mistranslation could induce resistance to stress and induce phenotypic 
variability. Cell tolerance to external stressors can be viewed as a secondary effect of the 
activation of the environmental stress response (ESR) caused by mistranslation (101).  
 However, the classical response to stress found in S. cerevisiae is not observed in 
C. albicans. C. albicans only has a small number of genes (about 20) implicated in the core 
stress response. The common stress response is mainly regulated by Hog1 SAPK (stress-
activated protein kinase) and the transcription factor Cap1 (102, 103). Cap1 possess three 
conserved cysteine residues in the C-terminal region that become oxidised under oxidative 
stress (104). This induces its nuclear accumulation and subsequent activation of the target 
genes, which have antioxidant functions (e.g. catalase, glutathione reductase). In 
accordance, Cap1 inactivation decreases the expression of these genes (103). Thus, Cap1 is 
considered a key player in the transcriptional response to the reactive oxygen species 
(ROS) produced by the host immune cells (102-104). Hog1 is an element of the 
evolutionary conserved mitogen activated protein kinase (MAPK) family, which is 
involved in the response to osmotic stress in yeast. In presence of cationic and osmotic 
stressors, such as NaCl and KCl, Hog1 is activated by phosphorylation and it accumulates 
in the nucleus, leading to the activation of the target genes (e.g. a glycerol phosphatase) 
(102, 105). Additionally, Hog1 SAPK is also activated in response to heavy metals, heat 
and oxidative stress (106). Cells with defective Hog1 SAPK function presented impaired 
virulence in mouse models (107). 
 1.4.4  C. albicans interactions with host 
The ability of C. albicans to survive and infect different host locations is supported 
by a number of virulence factors and other factors that promote the virulence without 
interacting directly with the host (fitness attributes). Virulence factors include expression 
of adhesins and invasins on the cell surface, which allow the complex adherence to the 
surface of the host and then permit the penetration in epithelial tissue (81, 108). Phenotypic 
switching between yeast to hyphal form is considered essential for invasion and 
pathogenicity. Biofilm formation is another important virulence factor, considering that 
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these are constituted by groups of cells embedded in an extracellular matrix material that 
protects cells from antifungals and immune defense (109, 110). Additionally, fitness 
attributes comprise adaptation to changes in environmental pH, temperature and robust 
stress response (102, 110). These properties and the genomic flexibility that has been 
previously described suggest that C. albicans can undergo specific genomic changes in 
order to survive stresses in the human host (111). 
 It is thought that there is a limit of C. albicans cells that the host can tolerate and 
that immune system must distinguish not threatening from invasive fungal cells in order to 
keep homeostasis. The first barrier of defence is the epithelial cells and its produced 
cytokines (81). When the microbial flora is unstable or the immune system is 
compromised, C. albicans cells can penetrate the epithelium and invade bloodstream. 
Following that, the host innate immunity recognizes and initiates a response (112). The 
initial response to the infection is determined by the recognition of fungal cell wall 
components, known as pathogen associated molecular patterns (PAMPs), pattern 
recognition receptors present on the surface of the nonspecific immune system cells (81, 
113). These cells are mainly phagocytes, such as neutrophils, monocytes, macrophages and 
dendritic cells (114). Macrophages are one of the most important in the response to  
C. albicans. Once macrophages recognize the yeast PAMPs, it is initiated the process of 
phagocytosis. After being phagocytized, pathogens are exposed to low pH and cytotoxic 
products, namely reactive oxygen and reactive nitrogen species. After processing the 
pathogen antigens, macrophages display them on the surface to be recognized by T cells 
and trigger adaptive immunity (112).  
 As mentioned above, C. albicans has developed mechanisms to survive and escape 
the host immune system. Thus, elucidating the pathways that regulate stress in C. albicans 
may be important to better understand host-pathogen interactions. 
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1.5  Working hypothesis and objectives 
Previous studies by the host laboratory showed that within the C. albicans cytoplasm 
there are two charged forms of the tRNACAG
Ser
: the Leu-tRNACAG
Ser
 (3%) and the Ser-
tRNACAG
Ser
 (97%), and both compete for the CUG codon decoding at the ribosome A-site. 
However, it has also been demonstrated that the leucine misincorporation at CUG codons 
varies under different physiological conditions. Therefore, the main objective of this 
Master’s thesis was to identify molecules and pathways involved in the regulation of 
mistranslation, and ultimately contribute to a better knowledge of this C. albicans unique 
feature. Since the tRNACAGSer has been identified as being responsible for CUG ambiguity, 
we hypothesized that Leu and Ser misincorporation is dependent upon competition 
between the LeuRS and SerRS for that tRNACAG.To test this hypothesis, this study has the 
following specific objectives: 
1. Quantification of SerRS and LeuRS expression in different physiological 
conditions; 
2. Correlate LeuRS/SerRS levels with Leu/Ser misincorporation levels; 
3. Identification of potential transcription factors that control LeuRS and SerRS 
expression.
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2.1  Strains and growth conditions 
2.1.1 Strains 
Escherichia coli strain JM109 (recA1 SupE44 endA1 hsdR17 gyrA96 relA1 thi 
Δ[Lac-proAB] F'[traD36 proAB-lacI lacZΔM15) was used as a host for all DNA 
manipulations. Candida albicans strain SN152 (arg4∆/ arg4∆ leu2∆/ leu2∆ his1∆/ his1∆ 
URA3/ura3∆::imm434 IRO1/iro1∆::imm434) was used by Homann et al (115) to construct 
the transcription factor (TF) deletion library used in this study. All C. albicans strains are 
described in table 2.1.  
 
Table 2.1 – List of C. albicans strains used in this study.  
Strain Description Deletion 
SN152 Control strain from the TF deletion library (ref Homann) ------ 
PHO4 Knock-out strain of the bHLH transcription factor of the myc-family Double 
19.2730 Has domain(s) with predicted zinc ion binding activity unknown 
STB5 Putative transcription factor with zinc cluster DNA-binding motif Double 
BAS1 Putative transcription factor with zinc cluster DNA-binding motif Double 
GLN3 GATA transcription factor Double 
RTG1 
Sequence-specific DNA binding RNA polymerase II transcription 
factor activity 
Double 
CUP2 Putative copper-binding transcription factor Double 
CWT1 Zn2Cys6 transcription factor Double 
ACE2 Transcription factor; similar to S. cerevisiae Ace2 and Swi5 Double 
MRR1 Putative Zn(II)2Cys6 transcription factor Double 
ZCF39 Zn(II)2Cys6 transcription factor Double 
HAP31 CCAAT-binding transcription factor; regulates CYC1 Double 
HAP43 CCAAT-binding factor-dependent transcription factor Double 
SKN7 
Predicted to be a response regulator protein in a phosphorelay signal 
transduction pathway 
Double 
HAP2 CCAAT-binding transcription factor Double 
OPI1 Leucine zipper transcription factor Double 
HAP5 Component of CCAAT-binding transcription factor Double 
HAP3 
Predicted CCAAT-binding transcription factor that regulates 
respiration 
Double 
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MSN4 Zinc finger transcription factor Double 
ASH1 GATA-like transcription factor Double 
TEC1 TEA/ATTS transcription factor Double 
19.173 C2H2 transcription factor. Double 
CAP1 AP-1 bZIP transcription factor Double 
19.2315 Putative transcription factor with bZIP DNA-binding motif Double 
ZCF5 Zn(II)2Cys6 transcription factor Double 
19.1150 GATA-like transcription factor Double 
STP2 Amino-acid-regulated transcription factor Double 
 
2.1.2 Standard growth conditions 
E. coli cells were grown at 37ºC in LB (1% peptone from casein, 0.5% yeast 
extract, 1% sodium chloride; Formedium) broth medium or LB 2% agar (Formedium). 
When necessary media was supplemented with ampicillin (75µg/ml; Sigma-Aldrich).  
C. albicans strains were grown at 30ºC in YPD (2% glucose, 1% yeast extract, 1% 
peptone; Formedium). C. albicans strains from the TF deletion library, carrying plasmids 
pUA563 and  pUA564 (table 2.3), were grown in minimal medium (MM) lacking arginine 
(0.67% yeast nitrogen base without amino acids, 2% glucose, and 0.2% drop-out mixture 
with all the required amino acids; Formedium). 
2.2  Primers 
 Primers used in this study were purchased from IDT
®
 (Integrated DNA 
Tecnologies) and were diluted in milli-Q water to a final stock concentration of 100µM. 
The primers design was made with OligoCalc software to check their properties 
(http://www.basic.northwestern.edu/biotools/oligocalc.html) (116). All primers used in this 
study are listed in table 2.2. 
 
Table 2.2 – List of primers used in this study.  
Primer 
name 
 Primer sequence (5’ 3’) Tm (ºC) 
oUA 1515 URA3 amplification GCCCCTTTTACAGTTGAA 54 
oUA 1516 URA3 amplification AGTGACACCATGAGCATT 55 
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oUA 1554 
Confirmation of plasmid 
integration at RP10 locus 
CGTATTCACTTAATCCCACAC 51 
oUA 1555 
Confirmation of plasmid 
integration at RP10 locus 
CCAATTGGTGATGGTCC 50.5 
oUA 1844 ARG4 amplification TTTGCGGCCGCTAGAACTAGCTTGATG 65.1 
oUA 1846 ARG4 amplification TTTACTAGTAGGTATAGAAATGCTGGT 54.5 
 
2.3  Plasmid construction  
2.3.1 Plasmids for LeuRS/SerRS quantification 
In order to determine the levels of the SerRS and LeuRS expression, the host 
laboratory previously constructed a reporter system for indirect quantification of these 
proteins. Plasmid pUA563 contains the reporter for determination of SerRS expression 
while pUA564 contains the reporter for determination of LeuRS expression (table 2.3; 
maps in annex A.1). Both reporters are based on the integrative vector CIp20 (117) and 
both rely on the yeast enhanced green fluorescent protein (yEGFP) expression. In pUA563, 
the open reading frame of this probe is fused to the promoter of the SerRS (SES1), so the 
fluorescence is proportional to the synthetase expression. In pUA564, the open reading 
frame of yEGFP is fused to the promoter of the LeuRS (CDC60). Additionally, both 
reporter systems have the mCherry gene associated with the actin promoter (ACT1) that 
works as internal control. These plasmids also had arginine (ARG4 gene) as a selective 
marker and both were used to transform the TF knockout collection and the control strain 
listed in table 2.1. 
 
Table 2.3 – Plasmids used in this thesis that were previously constructed by the host laboratory.  
Plasmid Description 
pUA 563 
Plasmid containing the yEGFP reporter system associated with the SES1 promoter, 
allowing the determination of SerRS expression; used to transform WT and TF KO strains 
with ARG 4 as selective marker 
pUA 564 
Plasmid containing the yEGFP reporter system associated with the CD60 promoter, 
allowing the determination of LeuRS expression; used to transform WT and TF KO 
strains with ARG 4 as selective marker 
pUA 553 
Plasmid containing the yEGFP reporter system with a WT TTA-leucine at position 201; 
URA3 gene is present as a selective marker 
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2.3.2 Plasmids for quantification of Leu misincorporation 
To quantify Leu misincorporation levels in knock-out C. albicans strains, we used a 
gain of function fluorescent reporter system also based on yEGFP, described by Bezerra et 
al. (76). This reporter system consists of three different versions of the yEGFP gene 
assembled in three different plasmids previously built by the host laboratory (pUA 553, 
pUA 554, pUA 555). The plasmid pUA 553 contains the yEGFP gene with WT TTA-
leucine at position 201 and functions as the positive control; plasmid pUA 554 has the 
codon at position 201 mutated for the ambiguous CTG codon, thus producing stable GFP 
only when Leu is incorporated; plasmid pUA 555 encodes the TCT-serine codon at 
position 201 of the yEGFP gene, thus producing inactive GFP (negative control). All of 
these three plasmids have URA3 as auxotrophic marker (table 2.3; maps in annex A.2).  
However, since the strains from the TF deletion library used in this study were 
generated with URA3 selective marker, we had to replace the URA3 gene from plasmids 
pUA 553, pUA 554 and pUA 555 with another selective marker. We substituted the URA3 
gene with ARG4 to transform strains from the TF knockout collection. First, the three 
plasmids were digested with SpeI and NotI (Fermentas) to remove the URA3 selective 
marker following the recommendations of the manufacturer. Then, ARG4 gene was 
amplified from plasmid pUA 564 using the forward oUA1844 and the reverse oUA1846 
primers. After this, the ARG4 insert was digested with SpeI and NotI enzymes. Prior to the 
insertion of the selective marker into the vectors, plasmids were treated with SAP enzyme 
(Shrimp Alkaline Phosphatase, Fermentas) to prevent re-ligation of the plasmids ends. 
Finally, ARG4 gene was assembled between SpeI and NotI restriction sites in the plasmids 
pUA 553, pUA 554 and pUA 555, resulting in the plasmids pUA 567, pUA 568 and pUA 
569, respectively (table 2.4; maps in annex A.3).  
 
 
pUA 554 
Plasmid containing the yEGFP reporter system with a  CTG ambiguous codon at position 
201; URA3 gene is present as a selective marker 
pUA 555 
Plasmid containing the yEGFP reporter system with a TCT-serine codon at position 201; 
URA3 gene is present as a selective marker 
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Table 2.4 – Constructed plasmids during this study.  
 
2.4  Expression of host transformation 
2.4.1 Preparation of E.coli competent cells 
 For the preparation of competent E. coli cells, we performed the TFB method (118) 
using cells from strain JM109. Initially, 200μl of cells from an overnight culture were 
inoculated in 5ml of LB medium and incubated at 37ºC with 180rpm until we obtained an 
OD600 of 0.3. After this, 4ml of the previous culture was inoculated in 100ml of LB 
medium and incubated at 37ºC with 180rpm until the OD600 was 0.3. Then, cells were 
collected in two 50ml falcons and kept on ice for 5 minutes. The two falcons were then 
centrifuged at 2500rpm for 5 minutes at 4ºC. Supernatant was discarded and each pellet 
was resuspended in 20ml of cold TFB I solution (0.03mM potassium acetate, 0.08mM 
RbCl2, 0.013mM CaCl2, 0.08mM MnCl2, 15.4% glycerol, pH 5.8). Tubes were then 
centrifuged at 2500rpm for 5min. at 4ºC. Supernatant was again discarded and each pellet 
was resuspended in 2.5ml of cold TFB II solution (0.01mM MOPS Na, 0.01mM CaCl2, 
0.008mM RbCl2, 13.4% glycerol, pH 6.5). Finally, cells were cooled on ice for 5 min. and 
then distributed in 200μl aliquots and frozen at -80ºC. 
2.4.2 Transformation of E. coli  
Transformation of E. coli cells was performed following the Sambrook’s SOC method 
(118). First, 20µl of ligation reactions using 1:0 to 1:5 of vector to insert ratios were 
prepared. In addition, the reaction contained 1µl of DNA Ligase (5U/µl) (Thermo 
Scientific), 2µl of 10x DNA Ligase Buffer (Thermo Scientific) and milli-Q water to 
complete the volume. Tubes were then incubated at 20ºC for 4h, followed by an incubation 
Plasmid Description 
pUA 567 Plasmid derived from pUA 553 containing an ARG4 gene as selective marker inserted 
between SpeI and NotI restriction sites 
pUA 568 Plasmid derived from pUA 554 containing an ARG4 gene as selective marker inserted 
between SpeI and NotI restriction sites 
pUA 569 Plasmid derived from pUA 555 containing an ARG4 gene as selective marker inserted 
between SpeI and NotI restriction sites 
Chapter II – Material and Methods 
28 
 
of 10 minutes at 65ºC to inactivate the enzyme. Next, ligation reactions were added to 
200µl aliquots of E. coli JM109 competent cells. Then, the reaction was incubated on ice 
during 30 minutes, followed by a heat shock at 42ºC for 90 seconds and iced again for 2 
minutes. After that, 800µl of SOC medium (for preparation of 100ml at pH 7.2g of 
tryptone, 0.5g of yeast extract and 0.05g of NaCl were weighted, and 1ml of KCl 250mM 
and 20ml of glucose 1M were added) was added to each reaction and tubes were incubated 
for 1h at 37ºC with agitation of 180rpm. Next, tubes were centrifuged during 1 minute at 
2500rpm. The resulting supernatant was discarded and the pellet was homogenized and 
plated into LB plates supplemented with 75µg/ml ampicillin (Sigma-Aldrich). Plates were 
incubated overnight at 37ºC.  
2.4.3 Plasmidic DNA purification from E.coli 
 For the plasmidic DNA purification and extraction from E.coli, we used the 
“NZYMiniprep” kit (Nzytech,). For this, E. coli cells were grown overnight in 5ml of 
liquid LB medium (Formedium) with ampicillin (75µg/ml; Sigma-Aldrich). The procedure 
was then performed according to the manufacturer’s instructions. After the purification, 
NanoDrop was used to quantify the yield of the purified DNA. Purified plasmids were 
stored at -20ºC until further use.  
2.5  Manipulation of C. albicans strains 
2.5.1 Transformation of C. albicans 
Prior to the transformation protocol, plasmids were linearized with StuI (Thermo 
Thecnologies) following the recommended reaction conditions, during 4h at 37ºC. 
Transformation of C. albicans was then carried out using an improved lithium 
method with minor modifications (119). C. albicans cells were grown overnight in falcon 
tubes with 10ml liquid YPD medium. These cultures were then diluted into fresh YPD 
medium to an OD600 of 0.3 and grown for additional 4 hours at 30ºC, 180rpm shaking until 
cell cultures reached an optical density of 1-1.2 at 600nm. Cells were then centrifuged at 
4000rpm for 5 min, supernatants were discarded and pellets were resuspended in 150µl of 
LiAc-solution (10% of LiAc 1M, 10% TE buffer 10x, 80% of milliQ-water). In an 
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Eppendorf tube, 200µl of the cell suspension, 5µg of the plasmid DNA of interest and 50µl 
of carrier single strand DNA (2mg/ml) were mixed. To the transformation mixture 600µl 
of PEG/LiAc-solution (50% (w/v) polyethyleneglycol, 50% LiAc-solution) was added and 
briefly vortexed. Afterwards, the transformation tubes were incubated overnight at 30ºC, 
followed by a heat shock of 15 min. at 44ºC and another on ice for 2 min. Cells were 
pelleted at 4000rpm for 5 min and resuspended in appropriate minimal medium. Aliquots 
of 100µl of cell suspensions were plated onto selective medium plates and incubated at 
30ºC during 3-4 days. 
2.5.2 DNA extraction from C. albicans 
We performed DNA extraction from the selected yeast transformants, using an 
adaptation of the lyticase method developed by Hoffman and Winston (120). First,  
C. albicans cells were grown overnight in 5ml of appropriate minimal medium at 30ºC. 
Cells were than centrifuged at 4000rpm for 5min and the supernatant discarded. Then, cells 
were resuspended in 500µl of Solution I (sorbitol 1M; EDTA-Na2 20mM; pH 7) and 
transferred to an Eppendorf tube. This step was followed by the addition of 4µl (10 mg/ml) 
of the lyticase enzyme (Sigma-Aldrich) and incubation at 37ºC for 60 min. Tubes were 
then centrifuged for 3 min at 13000rpm and the supernatant discarded. 500µl of Solution II 
(Tris-HCl 50mM; EDTA-Na2 20mM; pH7) and 50µl of SDS were added and samples were 
vortexed. This was followed by incubation at 65ºC for 30 min. 200µl of Potassium Acetate 
5M were added and samples were incubated on ice for 60 min. The suspensions were 
centrifuged for 5 min. at 13000rpm and the supernatant (600µl) transferred to another 
Eppendorf tube. Then, 1.5V of cold ethanol 100% and 0.1V of NaCl 5M were added to 
each tube followed by an incubation at -30ºC for 2h. After this, tubes were centrifuged for 
5 min. and the supernatant was discarded. Pellets were air dried and resuspended milli-Q 
water. Finally, the DNA concentration was determined using NanoDrop
®
. 
2.5.3 Integration confirmation  
Integration of the different plasmids was targeted to the RP10 locus of C. albicans strains. 
To confirm the correct plasmid integration in E. coli, transformants were tested by colony 
PCR. Briefly, individual colonies were picked from selective media and homogenized in 
5µl of milli-Q water. Next, the suspension was submitted to 95ºC during 5 min. for cell 
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lysis. Then, amplification of the RPS10 locus fragment was performed according to current 
polymerase chain reaction (PCR) protocols. The following reagents were added to the 
suspension: 1X Dream Taq Buffer, 0.2mM dNTP mix (Fermentas), 0.15mM of each 
specific primer (table 2.3), 0.375U of Dream Taq polymerase and milli-Q water to a final 
volume of 15µl. The protocol for the PCR reaction was performed in My Cycler
TM
 thermal-
cycler (BIO RAD) and consisted on a denaturation step at 95ºC for 5 min, 30 cycles of 
denaturation at 95ºC for 30s, annealing temperature of 50ºC for 30s, extension at 72ºC for 
1 min and a final extension step at 72ºC for 5 min. PCR products were then checked by gel 
electrophoresis, running the samples on a 1 % agarose gel. 
2.6  Choice of transcription factors mutants to analyse 
The identification of putative transcription factors regulators of mistranslation was 
previously done by the host group through a bioinformatics analysis. This approach 
allowed the identification of TF binding sites present in the 1000 base pairs located 
upstream of the AUG start codon of LeuRS (CD60) and SerRS (SES1) open reading 
frames. For this, the two DNA sequences were submitted to the online tool motif finder 
“Find TF Binding Site (s)” from the YEASTRACT database (http://www.yeastract.com) 
(121). This tool retrieved a list of motif sequences and the corresponding transcription 
factors that bind to them. Since this is a yeast database, it was performed a search in the 
Candida Genome Database website (http://www.candidagenome.org) (122) for orthologs 
of the identified yeast TFs in Candida albicans. A list of 25 TFs with probable binding 
motifs in both promoters was obtained. Additionally, 2 TFs with no probable binding 
motifs in SES1 and CD60 promoters were chosen as controls. This bioinformatics analysis 
allowed the reduction of the screening from the initial 166 mutants in the deletion library 
to the 25 tested in this study (table 2.5). 
 
Table 2.5 – List of the C. albicans TFs selected for this study (selected from Homann et al.(115). 
TF ORF 
Gene Name 
(C. albicans) 
S. cerevisiae 
ortholog 
Description SerRS LeuRS 
4 19.1253 PHO4 PHO4 
bHLH transcription factor of the 
myc-family 
X  
8 19.2730  GIS1 
Has domain(s) with predicted zinc 
ion binding activity 
 X 
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13 19.3308 STB5 STB5 
Putative transcription factor with 
zinc cluster DNA-binding motif 
X X 
16 19.3809 BAS1 BAS1 
Putative transcription factor with 
zinc cluster DNA-binding motif 
X  
18 19.3912 GLN3 GLN3 GATA transcription factor X  
34 19.4722 RTG1 RTG1 
Sequence-specific DNA binding 
RNA polymerase II transcription 
factor activity 
X  
39 19.5001 CUP2 CUP2 
Putative copper-binding 
transcription factor 
X  
50 19.5849 CWT1 RDS2 Zn2Cys6 transcription factor --- --- 
59 19.6124 ACE2 ACE2 
Transcription factor; similar to S. 
cerevisiae Ace2 and Swi5 
X  
69 19.7372 MRR1 HAP1 
Putative Zn(II)2Cys6 
transcription factor 
X X 
73 19.7583 ZCF39  Zn(II)2Cys6 transcription factor X X 
79 19.517 HAP31 HAP3 
CCAAT-binding transcription 
factor; regulates CYC1 
X  
80 19.681 HAP43 HAP4 
CCAAT-binding factor-dependent 
transcription factor 
X  
83 19.971 SKN7 SKN7 
Predicted to be a response 
regulator protein in a 
phosphorelay signal transduction 
pathway 
X X 
87 19.1228 HAP2 HAP2 
CCAAT-binding transcription 
factor 
X  
90 19.1543 OPI1 OPI1 
Leucine zipper transcription 
factor 
--- --- 
93 19.1973 HAP5 HAP5 
Component of CCAAT-
bindingtranscription factor 
X  
108 19.4647 HAP3 HAP3 
Predicted CCAAT-binding 
transcription factor that regulates 
respiration 
X  
109 19.4752 MSN4 MSN4 Zinc finger transcription factor  X 
112 19.5343 ASH1 ASH1 GATA-like transcription factor X X 
115 19.5908 TEC1 TEC1 TEA/ATTS transcription factor  X 
136 19.173  AZF1 C2H2 transcription factor. X  
140 19.1623 CAP1 YAP1 AP-1 bZIP transcription factor X X 
142 19.2315  RTG3 
Putative transcription factor with 
bZIP DNA-binding motif 
X  
149 19.2315 ZCF5 HAP1 Zn(II)2Cys6 transcription factor X X 
157 19.1150   GATA-like transcription factor X X 
162 19.4961 STP2 STP2 
Amino-acid-regulated 
transcription factor 
X X 
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2.7  Stress conditions 
 To determine SerRS and LeuRS expression, as well as leucine incorporation at 
CUG sites, 3 clones from each selected transformed knockout and control strain were 
cultured in several physiological conditions. Strains were grown overnight in a specific 
liquid MM until exponential phase, as described in table 2.6. Samples were then spotted 
onto microscope slides and analysed by epifluorescence microscopy. 
 
 
Table 2.6- Conditions used in the stress experiments.  
Assay Stress 
compound 
Growth 
Temperature 
Control pH 7 30ºC 
Temperature 
30ºC 
37ºC 
30ºC 
37ºC 
pH 
pH 4 
pH 6 
pH 7 
30ºC 
30ºC 
30ºC 
Osmotic 
stress 
Sorbitol 0.2 M 
Sorbitol 1 M 
30ºC 
30ºC 
 
2.8  Epifluorescence Microscopy  
 To determine LeuRS and SerRS expression, yEGFP and mCherry expression of  
C. albicans cells was observed using epifluorescence microscopy. Fluorescence was 
detected using a Zeiss MC80 Axioplan 2 light microscope equipped with filter sets 38 HE 
GFP and 63 HE mRFP. Photographs were taken using an AxionCam HRc camera, and 
images were then analysed with ImageJ software. LeuRS expression was calculated in at 
least 300 cells carrying plasmid pUA564. For that, the mean intensity of the GFP 
(controlled by LeuRS promoter) was divided by the mean mCherry intensity. SerRS 
expression was obtained from cells carrying plasmid pUA563. The mean intensity of the 
GFP (controlled by SerRS promoter) was divided by the mean mCherry intensity, which 
allowed indirect quantification of the synthetase. 
 To quantify leucine incorporation at CUG sites, GFP fluorescence intensity was 
divided by the mCherry intensity obtained in the same cell. This GFP quantification was 
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performed for at least 300 cells carrying each version of the reporter:  pUA567 (Leu-
UUA201 - positive control), pUA568 (Ser/Leu-CUG201 - reporter) and pUA569 (Ser-
UCU201 - negative control). Then, values obtained in the negative strain were subtracted 
to the values obtained in the reporter and positive strains. After that, values resulting from 
the reporter strain are divided by the ones obtained in the positive strain (Equation 1).  
 
 
 
Equation 1: leucine incorporation at CUG sites 
2.9  Statistical Analysis 
All statistical analyses were performed using the GraphPad Prism version 5.0 software 
for windows. Data represent the mean (± standard deviation - s.d.) of three clones tested for 
each strain. Statistical comparisons between the deletion strains and the control WT strain 
were carried out using one-way ANOVA followed by a Dunnett comparison test with 95% 
interval with the control (***p<0.001, **p<0.01, *p<0.05). Heat maps were generated 
using the MeV software version 4.9 for windows. 
[GFPCUG (Reporter) /mCherry(Reporter)] – [GFPUCU (Negative)/ mCherry (Negative)] 
Leucine incorporation 
at CUG codons 
= 
[GFPUUA (Positive) /mCherry(Positive)] – [GFPUCU (Negative)/ mCherry (Negative)] 
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3.1   SerRS and LeuRS expression and CUG ambiguous decoding 
3.1.1  Overview  
Candida albicans has the remarkable capacity to adapt and cope with the immune 
system, including tolerance to extremes of pH, oxidative and nitrosative stress and stress 
associated with clinical therapies. In addition, this human pathogen decodes ambiguously 
the leucine CUG codons as serine (97%) and leucine (3%) using a hybrid tRNACAG
Ser  
(123). This serine tRNA
 
is aminoacylated by both SerRS and LeuRS, originating the 
incorporation of Ser and Leu at CUG sites, respectively (123). Therefore, there is a 
competition between SerRS and LeuRS for this hybrid tRNA, in which LeuRS (in normal 
conditions) seems to be the weakest competitor, as CUG is mainly translated as serine 
(124). Interestingly, Leu misincorporation is flexible and increases in response to stressful 
conditions (74), suggesting that LeuRS activity increases under stress. It was also 
demonstrated that both SerRS and LeuRS have a single CUG codon in highly conserved 
regions (99). Consequently fluctuations in the insertion of serine or leucine at CUG 
positions could affect their aminoacylation activities (25, 99). 
 To test our hypothesis, that Leu and Ser misincorporation at CUG codons is 
dependent upon competition between the LeuRS and SerRS for the tRNACAG
Ser
, we started 
by demonstrating that SerRS and LeuRS expression changes in conditions where 
fluctuation in CUG ambiguity was already proved. To do so, we used a fluorescent reporter 
system to indirectly quantify SerRS and LeuRS expression and established the existence of 
a correlation between increase in ambiguity (increase in Leu incorporation at CUG sites) 
and increase in LeuRS/SerRS ratio. 
 
3.1.2  SerRS and LeuRS expression in different physiological conditions 
In order to quantify SerRS and LeuRS expression we used two reporter systems 
based on expression of yeast-enhanced GFP (125), already available in the host laboratory. 
One of the reporter systems harbours the GFP open reading frame fused with the promoter 
of SerRS (SES1) gene and the other has GFP fused with the LeuRS (CD60) promoter. In 
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both cases, GFP fluorescence will be proportional to the activity of the promoter and, 
therefore, will indirectly measure expression of the gene that is associated with. 
Additionally, both reporters contain the mCherry gene fused to the actin promoter (act1) 
that was used to normalize protein expression levels (Figure 3.1).   
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 – Schematic representation of the reporter systems used to quantify LeuRS and SerRS 
expression.  
A) These reporter systems are based on yEGFP, where the open reading frame of GFP was fused to the 
promoters of the SerRS and LeuRS genes (SES1 and CDC60) and its fluorescence is proportional to their 
activity. A mCherry fluorophore associated with actin promoter (ACT1) was used as internal control. LeuRS 
and SerRS reporters were assembled into pUA564 and pUA563 respectively. B) Fluorescence and brightfield 
images of C. albicans cells obtained by epifluorescence microscopy (magnification: 630x) with the 
appropriate filters, using an AxionCam HRc camera (Zeiss). 
These reporter systems were integrated in the RP10 locus of C. albicans WT strain 
SN152 (115) and cells were grown under different physiological conditions: temperature, 
pH and osmotic stress. These conditions are particularly relevant because C. albicans is 
able to colonize different host sites, where it is exposed to temperature and pH fluctuations. 
Also, the pathogen is exposed to the candidacidal mechanisms of phagocytes, which 
includes hydrolytic activity promoted by acidic pH (114). In this study, we measured GFP 
fluorescence of cells grown at pH 4, pH 6 and pH 7 and temperature 30ºC and 37ºC,  
considering 30ºC and pH 7 as control growth conditions. A LeuRS/SerRS expression ratio 
A 
B 
SerRS 
SerRS promoter 
fused with GFP 
Reporter System 
LeuRS 
GFP 
CD60 
Promoter 
mCherry 
ACT1 
Promoter 
LeuRS promoter 
fused with GFP 
Act1 promoter fused 
with mCherry 
GFP 
SES1 
Promoter 
mCherry 
ACT1 
Promoter 
Act1 promoter fused 
with mCherry 
Integration of the reporter 
system at the RP10 locus of 
the selected strains 
 
GFP mCherry Brightfield GFP mCherry Brightfield 
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was established for all conditions. Cells grown at 37ºC, pH4 and pH6 presented an increase 
of LeuRS/SerRS ratio, compared to the cells grown at control conditions (Figure 3.2). 
 Another important characteristic of C. albicans is the resistance to osmolarity 
changes. Exposure to sorbitol induces increase in cell volume and cell wall alteration in C. 
albicans (126). The selected sorbitol concentrations were 0.2M and 1M and, similarly to 
the results obtained for the pH and thermal stress, cells grown in presence of sorbitol had 
higher LeuRS/SerRS ratio expression levels than the control (0M) (Figure 3.2). 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 – LeuRS/SerRS expression ratio in C. albicans WT strain SN152 grown at different 
physiological conditions.  
Values are presented as mean ± s.d. of LeuRS/SerRS ratio expression at control conditions (30ºC, 0M and 
pH7) and stress conditions (37ºC, Sorbitol 0.2M and 1M, pH 6) retrieved from at least 300 cells of 3 different 
clones (***p<0.001 vs control). 
These results raised an important question: the increase of LeuRS/SerRS expression 
ratio under stress conditions is caused by an increase of LeuRS or decrease of SerRS 
expression, or both? Therefore, an analysis of raw data concerning GFF intensity of both 
reporters allowed us to investigate the LeuRS and SerRS expression separately. Levels of 
LeuRS expression were higher in cells under all stress conditions tested, compared to 
control (figure 3.3A). In contrast, with the exception of the condition 0.2M sorbitol, SerRS 
expression was almost constant in all conditions (Figure 3.3 B). Thus, the increase of 
LeuRS/SerRS in response to stress seems to be mainly due to the increase of LeuRS 
expression.  
Thermal 
stress 
Osmotic 
stress 
pH stress 
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Figure 3.3 – LeuRS and SerRS expression in C. albicans WT strain SN152 grown at different 
physiological conditions.  
Data represents mean ± s.d. of LeuRS (A) SerRS (B) at control conditions (30ºC, 0M and pH7) and stress 
conditions (37ºC, Sorbitol 0.2M and 1M, pH 6) of at least 300 cells of 3 different clones (***p<0.001 vs 
control). Fluorescence intensity (arbitrary units) was measured using a Zeiss epifluorescence microscope and 
GFP intensity was normalized for mCherry intensity at each cell. 
3.1.3  Comparison of LeuRS/SerRS levels with Leu/Ser misincorporation levels 
 After the demonstration that LeuRS/SerRS levels increase under thermal, osmotic 
and pH stress, our second objective was to verify if it correlates with the CUG ambiguity 
previously measured in same conditions. To do so, we gathered the data of the 
quantification of Leu incorporation at CUG sites in cells grown at 30ºC and 37ºC from the 
work of Gomes et al. (74). Leu levels concerning the osmotic stress (0.2M, 1M) and pH (4, 
6 and 7) were obtained from unpublished work from the host laboratory (João Simões PhD 
thesis). Then, these Leu misincorporation levels were qualitatively compared with the ratio 
of LeuRS and SerRS expression that were obtained in this study. A positive correlation can 
be observed between the increase in LeuRS/SerRS and Leu misincorporation at CUG 
codons in all the stress conditions tested (Figure 3.4). This was an important finding, 
because it indicates that Leu and Ser misincorporation at CUG sites may indeed be 
dependent on LeuRS and SerRS expression. Therefore, based on our hypothesis, the next 
objective was the identification of putative regulators controlling LeuRS and SerRS 
expression. 
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Figure 3.4 – Comparison between Leu and Ser mistranslation at CUG sites and LeuRS/SerRS 
expression. A)  Data represents Leu misincorporation at CUG sites in different physiological conditions 
previously reported by Gomes et. al. (30ºC and 37ºC) and João Simões (Sorbitol 0.2M and 1M, pH 4, 6 and 
7). No statistics is shown as the graph represents indicative data retrieved from different bibliography and 
unpublished data from the host laboratory. (B) Ratio of the LeuRS and SerRS expression at control 
conditions (30ºC, 0M and pH7) and stress conditions (37ºC, Sorbitol 0.2M and 1M, pH 6) of at least 300 
cells of 3 different clones. Conditions where a positive correlation in ambiguity (increase in Leu 
incorporation) is accompanied by increase in LeuRS/SerRS ratio are marked with red arrows. (***p<0.001 
vs control). 
3.2  Identification of potential transcription factors that control LeuRS 
and SerRS expression  
3.2.1  Overview 
An adequate adaptation to stress is essential for cell surviving in severe 
environments. Induction of gene expression alterations is one important mechanism of 
stress response (127). Transcription factors (TFs) are key players in this process because 
they are intermediaries between the stress signals and the metabolic reprograming needed 
to respond to changes in the environmental conditions (128). In recent years, many studies 
have been exploring the role of TFs in C. albicans response to stress and virulence traits 
(128-130). 
 Stress tolerance in mistranslating C. albicans was already widely demonstrated. 
The random insertion of Leu and Ser at CUG sites generates a combination of mutant 
proteins important to tackle environmental changes (74, 76, 131). However, little is known 
Thermal 
stress 
Osmotic 
stress 
pH stress 
A 
Thermal 
stress 
Osmotic 
stress 
pH stress 
B 
Chapter III – Results  
42 
 
about how C. albicans regulates CUG ambiguity. The validation of our hypothesis, that the 
incorporation of Ser and Leu at CUG codons is dependent on the competition between the 
SerRS and LeuRS for the tRNACAG
Ser
, prompted us to study the control of CUG ambiguity 
through the identification of regulators of SerRS and LeuRS expression. The regulation of 
eukaryotic aaRSs genes is still not well studied. Nevertheless, in line with the observations 
in prokaryotes, it is proposed that both transcriptional and post-transcriptional mechanisms 
may be involved (132).  
 Taken all these findings into account, the study of TFs is a good starting point for 
the study of regulation of mistranslation. To accomplish this, we screened a C. albicans TF 
mutant collection, by transforming the strains with the fluorescent reporters to monitor the 
expression of SerRS and LeuRS under the physiological conditions tested in the previous 
section. 
3.2.2  Screening of TF knock-out collection 
 In order to identify potential regulators of LeuRS and SerRS expression, we took 
advantage of a pre-existent collection of 166 genetically matched strains of C. albicans, 
each of which has been deleted for a specific transcriptional regulator (115). As mentioned 
in the section 2.6, a bioinformatics analysis was previously done in the host laboratory. It 
was performed a search for TF binding sites present in the 1000 base pairs located 
upstream of the AUG start codon of LeuRS (CD60) and SerRS (SES1) open reading 
frames. To do so, the two DNA sequences were submitted to the online tool motif finder 
“Find TF Binding Site (s)” from the YEASTRACT database (http://www.yeastract.com) 
(121). Then, it was performed a search in the Candida Genome Database website 
(http://www.candidagenome.org) (122) for orthologs of the identified yeast TFs in 
Candida albicans. This analysis allowed us to narrow the screening from a collection of 
166 TF mutants to a group of 27 knockout strains. The list of the strains tested in this study 
is depicted in table 2.1 (section 2.1). 
After the transformation of these 27 strains with plasmids containing the 
fluorescent systems, 3 clones of each were grown under control the conditions (30ºC, pH 
7) and stress condition pH (pH 6) and osmotic stress (sorbitol 0.2M). At control conditions, 
most of the mutant strains showed a superior LeuRS/SerRS expression than WT strain 
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(Figure 3.5 A). Similarly, the majority of the mutant strains exposed to 0.2M concentration 
of sorbitol expressed a higher ratio of LeuRS/SerRS expression than the WT strain (Figure 
3.5 C). Contrarily, when grown in media with pH 6 (Figure 3.5 D) almost all deletion 
strains exhibit a lower LeuRS/SerRS expression than the WT. Strains grown at 37ºC 
presented a more heterogeneous behaviour. There were mutant strains that showed a lower 
LeuRS/SerRS expression than the WT strain, while others presented higher expression of 
LeuRS/SerRS expression (Figure 3.5 B).  
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Deletion strains lacking the TFs HAP3, STB5 and HAP2 showed high values of 
LeuRS/SerRS in all conditions, suggesting that these proteins could act as repressors of 
LeuRS expression. In contrast, mutant strain ASH1 showed a low ratio LeuRS/SerRS at 
37ºC and pH 6 and RTG3 at pH6, indicating that these genes can encode positive 
regulators of LeuRS expression under these environmental conditions. We reasoned that 
these are the most interesting mutants, because they exhibit statistically different 
LeuRS/SerRS expression ratios from the WT strain in the same pattern at least in two 
Figure 3.5 – Heat maps of the LeuRS/SerRS ratio expression in C. albicans TF deletion strains 
normalized to WT strain in several physiological conditions.  
Data from the TF KO collection and WT strain SN152 at control conditions (A), at 37ºC (B), sorbitol 0.2M 
(C), and pH6 (D). Ratio of the LeuRS and SerRS expression obtained from 300 cells of 3 clones 
from each KO strain were normalized to the WT strain values. Strains HAP3, STB5 and HAP2 
presented high values of LeuRS/SerRS in almost all conditions. In contrast, strains ASH1 showed 
a low ratio LeuRS/SerRS at 37ºC and pH6 and RTG3 in pH6. Red means higher LeuRS/SerRS 
expression than the control while green represents lower LeuRS/SerRS expr ession. (***p<0.001, 
**p<0.01, *p<0.05 vs control). 
0.3  1  3 
 
0.2M 
*** 
** 
** 
*** 
*** 
** 
* 
** 
** 
*** 
C D 
* 
0.3  1  3 
 
pH6 
Chapter III – Results  
45 
 
conditions (Figure 3.5). The 2 TFs chosen as controls, with no probable binding motifs in 
SES1 and CD60 promoters (OPI1 and RDS2), showed identical wild type LeuRS/SerRS 
expression at 37ºC and osmotic stress, but showed statistically differences at 30ºC. 
Although these 2 transcription factors were selected as controls from the bioinformatics 
analysis, we can not exclude the hypothesis that these factors may recognize motifs in the 
promoters of SerRS and LeuRS in C. albicans as the analysis was performed with tools 
developed for S. cerevisiae. Also, we can not exclude the possibility that these deletions 
are affecting other pathways with implications in the regulation of mistranslation beyond 
the transcriptional regulation of these aaRSs.  
3.2.3  Comparison of Leu misincorporation and LeuRS/SerRS ratio expression in 
TF knock-out collection 
 In order to validate the regulatory potential of the identified genes, Leu 
misincorporation levels in these deletion strains must have a positive correlation with 
LeuRS/SerRS expression. The rationale behind this validation is the following: if a mutant 
has increased LeuRS/SerRS and this is due to an increase in LeuRS and maintenance of 
SerRS (as seen in section 3.1.2), then that TF is a negative regulator (repressor) of LeuRS. 
Therefore, the deletion strain in question must have constitutive increased Leu 
misincorporation at CUG sites. In the opposite scenario: if a deletion strain has a decreased 
LeuRS/SerRS expression and this is caused by a decrease in LeuRS and maintenance of 
SerRS (as seen in section 3.1.2), then that TF is a positive regulator (enhancer) of LeuRS. 
Thus, in this case the mutant strain must present decreased levels of Leu misincorporation 
at CUG codons.  
To perform the quantification of Leu incorporation at CUG codons in the deletion 
strains, we used an established reporter system consisting of a gain of function fluorescent 
reporter system described by Bezerra et al. (76). Briefly, this reporter system includes three 
versions. In the positive control, at the position 201 of the GFP gene it is present the Leu-
TTA codon, essential to produce stable GFP and to obtain fluorescence. The reporter was 
mutated for the ambiguous CUG codon at position 201 so the obtained fluorescence will be 
proportional to the incorporation of Leu at this position. Finally, the negative control 
comprises the mutation of the Leu codon at position 201 to the Ser TCT codon, originating 
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inactive GFP. In addition, in each version the mCherry fluorophore is associated with the 
actin promoter (ACT1) and functions as internal control (Figure 3.6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The three plasmids containing the GFP constructions were integrated in the RP10 
locus of the WT and of the 5 candidate TF knockout strains. After that, 3 clones expressing 
each version of the fluorescent protein were submitted to the same growth conditions used 
to quantify SerRS and LeuRS expression. 
 When C. albicans WT (SN152) cells were cultivated at 30ºC (control condition) 
Leu incorporation at CUG-201 was 3 ± 0.70% (Figure 3.7B). As expected, globally the 
selected KO strains showed higher levels of Leu incorporation in the control conditions 
(Figure 3.7B). Performing a qualitatively comparison between Leu misincorporation levels 
and LeuRS/SerRS expression ratio collected at control conditions (Figure 3.7A), it is clear 
that there is a positive correlation in all the selected strains. Additionally, Leu 
misincorporation levels are not absolutely proportional to the LeuRS/SerRS expression 
ratio. For instance, HAP2 has the highest ratio of LeuRS/SerRS expression, but does not 
GFP mCherry 
ACT1 
Promote
r 
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Figure 3.6 – Schematic representation of the reporter system used to quantify Leu 
incorporation at CUG codons.  
This reporter system is based on the yeast enhanced green fluorescent protein ( yEGFP) 
described by Bezerra el al. (68). The Leu-TTA codon at position 201 was mutated to the 
ambiguous CTG codon (reporter) and to the Ser TCT codon (negative control).  The positive 
version was assembled into pU567, the reporter was integrated in the pUA568 and the 
negative control was assembled in the plasmid pUA569.  
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present the highest levels of Leu misincorporation at CUG sites (Figure 3.7A, B). The 
increase in Leu misincorporation in strains HAP2 and HAP3 is due to the increase of 
LeuRS expression, suggesting that under control conditions these transcription factors 
could be repressors of LeuRS expression (Figure 3.7C). In mutants ASH1, RTG3 and 
STB5, the increase in Leu misincorporation seems to be the result of increased expression 
of both LeuRS and SerRS (Figure 3.7C), suggesting a role of these TFs in the regulation of 
both enzymes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7 – Comparison of Leu misincorporation and LeuRS/SerRS ratio expression in WT 
strain SN152 and deletion strains ASH1, HAP3, HAP2, RTG3, and STB5 obtained at control 
conditions. 
A) LeuRS/SerRS expression ratio, (B) leucine misincorporation levels at CUG sites, (C) LeuRS and SerRS 
expression at control conditions (30ºC, pH7) in WT strain SN152 and deletion strains ASH1, HAP3, HAP2, 
RTG3 and STB5. Data retrieved from at least 300 cells of 3 different clones from each strain. (***p<0.001, 
**p<0.01, *p<0.05 vs control). 
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The Leu misincorporation level in WT (SN152) cells at 37ºC was 16.49 ± 1.43%, 
which is considerably higher compared with the values obtained at 30ºC. Mutant strains 
HAP3, HAP2 and STB5 showed higher levels of LeuRS/SerRS expression than the WT 
strain (Figure 3.8A). This increase of LeuRS/SerRS ratio was mainly due to enhancement 
of LeuRS expression (Figure 3.8C). However, the increase of LeuRS expression was not 
accompanied by a significantly increase of Leu misincorporation at CUG sites in these 
strains (Figure 3.8B). This data suggests that TFs HAP3, HAP2 and STB5 could influence 
LeuRS expression at temperature 37ºC, but it is not sufficient to alter the mistranslation 
rates. The mutant strain RTG3 that showed decreased LeuRS/SerRS expression (Figure 3.8 
A), did not showed a significantly decrease of Leu misincorporation compared to WT 
strain at 37ºC (Figure 3.8B). This decrease of Leu misincorporation is accompanied by an 
increase of SerRS expression and decrease of LeuRS expression (Figure 3.8C). 
Surprisingly, the mutant strain ASH1 showed inconsistent results. Previously, it had 
exhibited a decreased LeuRS/SerRS expression (Figure 3.8A), due to decrease of LeuRS 
expression (Figure 3.8C). However, Leu misincorporation in this strain was almost at wild 
type level. At 37ºC, it seems none of the identified TFs were validated.  
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WT cells under osmotic pressure induced by 0.2M sorbitol showed 4.27 ± 1.59% of 
Leu misincorporation at CUG sites. All the mutant strains tested displayed higher levels of 
Leu misincorporation than the control strain (Figure 3.9B). The increase of Leu 
misincorporation in the deletion strains was associated with the increase of LeuRS/SerRS 
expression (Figure 3.9A). In spite of the significant increase of both LeuRS and SerRS 
expression in response to osmotic stress in almost all strains (with the exception of HAP3 
that showed increased expression of LeuRS only), there was a clear higher LeuRS 
expression in relation to SerRS expression (Figure 3.9C). In line with the results from 
standard growth conditions, these results imply that TFs ASH1, HAP3, HAP2, RTG3 and 
STB5 could be repressors of LeuRS expression under osmotic stress. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8 – Comparison of Leu misincorporation and LeuRS/SerRS ratio expression in WT 
strain SN152 and deletion strains ASH1, HAP3, HAP2, RTG3, and STB5 obtained at 37ºC. 
A) LeuRS/SerRS expression ratio, (B) leucine misincorporation levels at CUG sites, (C) LeuRS and SerRS 
expression at 37ºC in WT strain SN152 and deletion strains ASH1, HAP3, HAP2, RTG3 and STB5. Data 
retrieved from at least 300 cells of 3 different clones from each strain. (***p<0.001, **p<0.01, *p<0.05 vs 
control). 
 
A B 
  
*** 
*** 
*** 
*** 
*** 
*** 
*** 
*** 
*** 
*** 
*** 
** 
*** 
** 
*** *** 
*** 
*** 
*** 
C  
Chapter III – Results  
50 
 
 
 
 
 
 
 
 
 
 
 
WT SN152 cells grown at pH 6 presented 16.80 ± 3.01% of Leu misincorporation 
at CUG codons. Deletion mutants HAP3, HAP2 and STB5 that revealed a decrease of 
LeuRS/SerRS ratio (Figure 3.9A), showed a slight decrease of Leu misincorporation 
compared to WT strain (Figure 3.9B). The decrease of LeuRS/SerRS ratio in mutant 
strains HAP3, HAP2 was associated with an increase of SerRS expression (Figure 3.9C). 
Once more, mutant strain ASH1 showed quite contradictory results. This mutant strain 
displayed LeuRS and SerRS expression levels similar to the WT strain when grown at 
media with pH 6 (Figure 3.9A, C). However, the misincorporation levels in this mutant 
strain were significantly higher than the WT strain (Figure 3.9B). The mutant strain RTG3 
showed an increase of LeuRS/SerRS ratio (due to a decrease of SerRS expression) and an 
increase of Leu misincorporation (Figure 3.9A, B). Thus, the deletion strain RTG3 was the 
only knockout strain that at pH6 showed an unequivocally positive correlation between the 
increase of LeuRS/SerRS ratio and Leu misincorporation. The fact that the increase of 
LeuRS/SerRS expression was mainly due to a decrease of SerRS expression indicates that 
RTG3 may act as an enhancer of SerRS expression. 
 
 
 
 
 
 
 
Figure 3.9 – Comparison of Leu misincorporation and LeuRS/SerRS ratio expression in WT 
strain SN152 and deletion strains ASH1, HAP3, HAP2, RTG3, and STB5 obtained under 
osmotic stress. 
A) LeuRS/SerRS expression ratio, (B) leucine misincorporation levels at CUG sites, (C) LeuRS and SerRS 
expression in presence of 0.2M of sorbitol in WT strain SN152 and deletion strains ASH1, HAP3, HAP2, 
RTG3 and STB5. Data retrieved from at least 300 cells of 3 different clones from each strain. (***p<0.001, 
**p<0.01, *p<0.05 vs control). 
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Overall, the validation approach allowed us to exclude ASH1 as a possible regulator 
of LeuRS/SerRS expression at 37ºC and at pH 6. RTG3 was validated as possible regulator 
of LeuRS and SerRS at 30ºC, osmotic stress and pH6. This transcription factor exhibited a 
possible dual role in the regulation of aaRSs expression as it may be repressor at 30ºC and 
osmotic stress but may function as enhancer at pH 6. Transcription factors HAP2, HAP3 
and STB5 might be repressors of LeuRS and SerRS expression at 30ºC and at 0.2 M.  
 
 
  
 
 
Figure 3.10 – Comparison of Leu misincorporation and LeuRS/SerRS ratio expression in 
WT strain SN152 and deletion strains ASH1, HAP3, HAP2, RTG3, and STB5 obtained at 
pH 6. 
A) LeuRS/SerRS expression ratio, (B) leucine misincorporation levels at CUG sites, (C) LeuRS and SerRS 
expression at pH 6 in WT strain SN152 and deletion strains ASH1, HAP3, HAP2, RTG3 AND STB5. Data 
retrieved from at least 300 cells of 3 different clones from each strain. (***p<0.001, **p<0.01, *p<0.05 vs 
control). 
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4.1 General discussion 
In this thesis we tried to shed light in how CUG ambiguous decoding is 
regulated in C. albicans. Initially, we tested if the expression of SerRS and LeuRS was 
correlated with the leucine misincorporation in different physiological conditions. To 
accomplish this we used a fluorescent reporter system already available in the host 
laboratory to assess the expression of both aaRSs in the conditions we already saw that 
ambiguity changes. Interestingly, it was observed a significant variation in the ratio of 
LeuRS/SerRS expression between the control conditions and all stress conditions tested. 
This was in accordance with our hypothesis and was in line with non-published results 
from a previous assay performed in the host laboratory. In the non-published 
experiment, LeuRS and SerRS expression was monitored by Western-blot in  
C. albicans cells grown under different physiological conditions and an increase in 
LeuRS/SerRS was detected in conditions where ambiguity was higher than the control.  
In this study, once the increase of LeuRS/SerRS expression under different 
conditions was demonstrated, we also evaluated if there was a correlation with an 
increase in ambiguity in the same conditions. Leu misincorporation at CUG sites has 
been previously measured in WT C. albicans cells by Gomes et al. (74) and João 
Simões (PhD thesis) in the host laboratory. In spite of the different approaches used to 
quantify Leu misincorporation, Gomes and colleagues performed Mass Spectrometry 
(MS) and João Simões built a fluorescent reporter system, both observed the same trend 
of increased ambiguity under stressful conditions. For example, the insertion of leucine 
at CUG codons in C. albicans cells is variable under different pH levels and the same 
trend was noticed in the LeuRS/SerRS ratio expression.  
C. albicans tolerates a wide range of environmental pH levels, from pH of <2 to pH of 
>10, yet fungi usually are more acidophilic than most of the pathogens (133). 
Nevertheless, our data also suggest that fluctuations of pH influence the LeuRS/SerRS 
balance (mostly due to LeuRS variation) and consequently, CUG ambiguity. In fact, a 
correlation between the LeuRS/SerRS expression and increase in Leu misincorporation 
was verified in all conditions tested (thermal stress, pH variation and osmotic stress), 
indicating that the differential expression of both enzymes may be responsible for the 
regulation of CUG ambiguity. 
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A previous study from Rocha et al. (99) revealed that SerRS contains a CUG 
codon at position 197, originating the isoforms SerRS_Ser197 and SerRS_Leu197 (99). 
The position 197 is located at the dimer interface of the enzyme, and substitution of the 
most frequent amino acid serine for leucine induces a local structural rearrangement, 
affecting an upstream region of the C-terminal domain which is probably involved with 
tRNA interactions (99). Also, an experiment carried out by João Simões (PhD thesis) in 
the host laboratory showed that C. albicans strains that only express the SerRS_Leu197 
incorporated higher levels of Leu at CUG codons than the strains that only express 
SerRS_Ser197. Furthermore, the LeuRS also owns a single CUG codon, located at the 
position 919 at the C-terminal tail. A previous study revealed that the change between 
the insertion of Leu or Ser at the position 919 does not affect the function or structure of 
the aminoacylation active site. However, the most common form LeuRS_Ser919 was 
30% less active than the isoform LeuRS_Leu919 (25). Altogether, these finding imply 
that Leu misincorporation may be regulated by a balance of LeuRS and SerRS isoforms 
with different affinities for the hybrid tRNACAG. 
These previous results from the host laboratory and the observation of an 
increase of LeuRS/SerRS ratio in cells under stress conditions lead to an important 
question: what is causing the increase in LeuRS/SerRS ratio; increase of LeuRS 
expression or decrease of SerRS expression? By analysing the data of each aminoacyl-
tRNA synthetase separately, we reached to the conclusion that the increase of 
LeuRS/SerRS ratio is mostly caused by a variation in LeuRS expression. In WT cells, 
values of SerRS expression were almost constant in all conditions (Figure 3.3), which 
suggest that this aaRS might be insensitive to environmental cues. These results oppose 
the proteomics analysis of C. albicans cells exposed to macrophages in which SerRS 
expression was downregulated (134). However, these results are in line with another 
study carried out by Gomes et al. (data not published). The alignment of the DNA 
sequence of LeuRS, SerRS and TrpRS (tryptophanyl tRNA synthetase) genes in 5 
different C .albicans strains revealed non-silent single nucleotide polymorphisms 
(SNPs) in the LeuRS gene, while SerRS and TrpRS genes had silent SNPs. In each 
strain, those polymorphisms account for 2 LeuRS isoforms with different promoters in 
both alleles. Such findings imply that LeuRS gene is regulated by transcription and that 
leucine incorporation at CUG sites may be modulated by the differential expression and 
affinity for the tRNACAG
Ser
 of the 2 LeuRS isoforms. Therefore, it was proposed that in 
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response to stress conditions, specific transcriptions factors would be activated and 
would enhance the expression of the isoforms with higher affinity for the tRNACAG
Ser
. 
As a result, there would be an increase of tRNACAG
Ser 
charged with Leu to compete with 
the Ser- tRNACAG
Ser 
for the CUG codons.  
Most of the pathways regulating aaRSs in response to environmental changes 
involve uncharged tRNAs that act as sensors and activate the regulatory reactions. 
Although, the regulatory mechanisms are not the same between organisms and aaRSs it 
has been demonstrated that both transcriptional and post-transcriptional mechanisms are 
involved (132, 135). To date, little is known about the regulation of aaRSs in 
eukaryotes. Perhaps the most well-known case is the regulation of AspRS (Aspartyl-
tRNA synthetase) in Saccharomyces cerevisiae. A model for AspRS feedback 
regulation proposed by Frugier et al. states that the excess of AspRS in the cytoplasm is 
imported in the nucleus and inhibits its own transcription by binding to the 5’ 
untranslated region (5’UTR) and 5’ extremity of its coding mRNAAspRS. Moreover, the 
transcribed tRNA
Asp
 can compete with the mRNA
AspRS 
for the AspRS, hence releasing 
the AspRS from its own inhibition (132). 
To investigate the regulatory mechanisms of LeuRS and SerRS, we started by 
screening 27 TFs (description list on section 2.6, table 2.5) from a TF deletion library 
constructed by Homann et al. (115). The LeuRS/SerRS ratio expression of the deletion 
mutant strains was assessed in the different physiological conditions where we 
previously had established a positive correlation with ambiguity. We considered 
promising regulatory candidates, TFs whose mutants exhibited statistically different 
LeuRS/SerRS expression ratios from the WT strain in at least in two tested conditions. 
A global look at the screening results showed that the deletion strains do not 
show the same behaviour through the different stress conditions tested. This is not 
entirely unexpected, because TFs normally only become activated under specific 
conditions (136). However, this also represents one of the caveats that must be kept in 
mind while analysing the results from the knockout collection. If the inducing signals of 
the TFs are not entirely known, one cannot be sure if the lack of difference relative to 
the wild type is due to the environmental condition tested or if the TF actually does not 
affect the expression of the LeuRS or SerRS at that particular condition. 
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At control conditions (30ºC), most mutant strains showed a higher LeuRS/SerRS 
than the WT strain with LeuRS being the one with a marked increased expression. In 
this manner, this data suggests that at 30ºC, most of the TFs assessed could act as 
repressors of LeuRS. Another possible explanation is that the knockout of some TFs by 
itself can be stressful for C. albicans cells. Consequently, mistranslation rates are higher 
than in WT cells and is reflected in a higher LeuRS/SerRS ratio. Similar results were 
obtained in response to osmotic stress, while at 37ºC there were strains whose deleted 
TF could function as repressors or enhancers of LeuRS expression. Strikingly, when the 
mutant strains were grown in media at pH 6, the LeuRS/SerRS expression tended to be 
lower than the WT strain. This implies that the lacking of those TFs could impair 
LeuRS activation under pH fluctuations. Accordingly, the analysis of LeuRS/SerRS 
expression individually for each physiological condition retrieved us a variety of 
regulators. The possibility that the LeuRS and SerRS have such an amount of regulators 
is quite low. For this reason, we considered a pattern across all conditions tested and 
detected 5 possible regulators: ASH1, HAP2, HAP3, RTG3 and STB5. 
ASH1 is a GATA-like transcription factor required for filamentous growth and 
virulence in mouse model (122, 137) . In addition ASH1 mRNA is often transported to 
daughter cells and hyphal tips for the She system, a complex responsible for the 
transport of mRNAs from mother to daughter cell during mitosis (138). In this 
screening, the mutant strain lacking ASH1 showed increased LeuRS/SerRS expression 
at 30ºC and in response to osmotic stress, thus could have a role as negative regulator of 
LeuRS and SerRS. Surprisingly, at 37ºC ASH1 mutants exhibited a lower LeuRS/SerRS 
expression that did not influence the level of CUG ambiguity. This finding is rather 
interesting, because 37ºC is an inducing condition of hyphal growth (86), thus a 
condition where ASH1 is required. 
 HAP2 and HAP3 are CCAAT-binding TFs, which are regulatory sequences for 
induction of the ferric reductase FRP1 in iron limited environments (122, 139). FRP1 
expression is induced by neutral-alkaline pH, which is the range of pH of most of the 
human body sites (139).  HAP2 and HAP3 deletion strains demonstrated identical 
LeuRS/SerRS expression rates. Our data suggested that these TFs could act as 
repressors of LeuRS expression at the thermal and osmotic conditions tested.  
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RTG3 is one of the helix-loop-helix/leucine zipper (bHLH/Zip) transcription 
factors that activate the RTG pathway, a cellular stress response activated by alteration 
in mitochondrial functions. In addition, RTG3 induces tolerance to azoles and 
terbinafine antifungals and cations (122, 140).  RTG3 was the only TF whose data 
implied a role as enhancer of SerRS expression at pH 6. Results concerning the thermal 
and osmotic stresses conveyed a repressor role of LeuRS expression.   
STB5 is a TF that belongs to the fungal specific zinc cluster Zn2-Cys6 class 
(141) and is thought to have a role in filamentous growth (122). The strain lacking this 
TF displayed similar results to the mutant strains HAP2 and HAP3. 
To validate the regulatory potential of these 5 candidates, we chose an already 
established fluorescent reporter system to quantify Leu misincorporation (76). This 
approach allows the quantification of Leu misincorporation at the single cell level and is 
less complex than mass spectrometry (MS) technique performed by Gomes et al.(74). 
The levels of Leu misincorporation in WT cells detected in this study were 
tendentiously higher than the levels obtained by Gomes et al. (74) using MS. However, 
the proportion of Leu misincorporation among the physiological conditions is 
maintained. We detected 3.02% and 16.49% of Leu misincorporation at 30ºC and 37ºC, 
while Gomes et al. obtained at the same conditions 2.96% and 3.9% respectively (74). 
When WT cells were grown at pH6 and osmotic stress (0.2M of sorbitol) we obtained 
16.80 % and 4.27% respectively, while João Simões (PhD thesis) obtained 11.7% and 
9.2% respectively. Using the fluorescent reporter system, we validated all the TFs at the 
control conditions and osmotic stress. All deletions showed a positive correlation 
between increase of LeuRS/SerRS expression and increase of Leu misincorporation. 
This means, that TFs ASH1, HAP2, HAP3, RTG3 and STB5 could be repressors of 
LeuRS and SerRS expression. The possibility that these TFs are regulating LeuRS 
expression is rather intriguing, because only ASH1 and STB5 have predictive DNA 
binding motifs in LeuRS promoter in our bioinformatics analysis. HAP2, HAP3 and 
RTG3 only showed specificity for the SerRS promoter. We must highlight the fact that 
the bioinformatics tools used were designed for S. cerevisiae. Thus, even if the list of 
TFs tested in this study has orthologs in S. cerevisiae, the DNA binding motifs may not 
be the same in both organisms. Despite the proximity between these two organisms, 
transcriptional rewiring is common (115, 136).  
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However, at 37ºC none of the deletion strains was validated. Despite the 
alterations in LeuRS/SerRS expression, there were no significantly differences in Leu 
misincorporation levels in the knock-out strains tested. Nevertheless, at this point we 
cannot rule out the possibility that the high incorporation of Leu observed in the WT 
strain (16.49%) influenced these results. 
When cells were grown at pH 6, only one mutant strain (RTG3) is immediately 
validated as possible repressor of LeuRS expression, as the expected increase of Leu 
misincorporation at the CUG sites was observed. However, we highlight the fact that in 
strains HAP2, HAP3 and STB5 the expected trend of decreased Leu misincorporation 
was observed (although with no statistical significance). 
A summary of the validation results is depicted in table 4.1 but the regulatory 
role of ASH1, RTG3, HAP2, HAP3 and STB5 in LeuRS and SerRS expression should be 
further investigated.  
 
Table  4.1 – Summary of the validation results of the identified transcription factors. 
 
 
30ºC 37ºC Osmotic stress (0.2M) pH6 
 
LeuRS SerRS LeuRS SerRS LeuRS SerRS LeuRS SerRS 
ASH1 Repressor Repressor - - Repressor Repressor - - 
HAP2 Repressor - - - Repressor Repressor - - 
HAP3 Repressor - - - Repressor - - - 
RTG3 Repressor Repressor - - Repressor Repressor - Enhancer 
STB5 Repressor Repressor - - Repressor Repressor - - 
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4.2 Main conclusions and future perspectives 
 
This work provided the first insight into the transcriptional regulation of CUG 
mistranslation in C. albicans. Our data showed that an increase of Leu misincorporation 
is accompanied by an increase of LeuRS/SerRS expression. This data supports the 
hypothesis that the insertion of leucine and serine at CUG codons is dependent upon the 
competition between LeuRS and SerRS for the tRNACAG
Ser
. In WT cells, the differential 
expression of LeuRS/SerRS seen in non-optimal conditions may be caused by 
fluctuations in LeuRS levels, while SerRS seems to be stress insensitive. It would be 
important to validate the expression LeuRS and SerRS obtained in this work using 
Western blot. Due to the fact that both SerRS and LeuRS have an ambiguous CUG 
codon, the kinetic parameters of the aminoacylation reaction of the different isoforms of 
LeuRS and SerRS should also be determined. It would be interesting to evaluate if the 
different isoforms of the enzymes have specific regulatory mechanisms. 
 This thesis identified the transcription factors ASH1, HAP2, HAP3, RTG3 and 
STB5 as possible regulators of LeuRS/SerRS expression. However, future experiments 
are warranted to clarify the function of each one of these proteins in the aaRSs 
regulation. Using the same approach of this study, it would be interesting to grow the 
identified knock-out strains in the condition where the highest level of Leu 
incorporation was observed (João Simões, PhD thesis). In this case, exposure of  
C. albicans cells to macrophage and amphotericin B causes an increase of ambiguity up 
to 50% and the regulatory potential of the mutant strains should accompany this 
considerable increase. This could be accomplished by performing a macrophage 
phagocytosis assay, co-culturing ASH1, HAP2, HAP3, RTG3 or STB5 mutant  
C. albicans cells with a differentiated human monocyte/macrophage cell line.   
Finally, in the host laboratory, at the same time of the screening of the TF 
knockout strain collection, it was performed a screening of a kinase knockout strain 
collection for potential SerRS and LeuRS regulators. In the near future it will be 
interesting to cross the data from both screenings. To unveil the regulatory circuits and 
identify the full gene regulatory spectra of CUG mistranslation is imperative to conduct 
an identification of the transcription factor binding sites (of the identified 5 TFs) in the 
LeuRS and SerRS promoters. LeuRS and SerRS promoter recruitment of ASH1, HAP2, 
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HAP3, RTG3 and STB5 should be confirmed by Chromatin Immunoprecipitation (ChIP) 
followed by quantitate real time PCR (qRT-PCR). 
Recent data strongly suggests a major role for CUG ambiguity on C. albicans 
pathogenesis by modulating host-pathogen interactions (76). Hence, we are hopeful that 
data from this study, together with follow up experiments, will contribute to uncover the 
regulators of CUG ambiguity and ultimately clarify the role of mistranslation on  
C. albicans virulence. 
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Annexes  
A.1 – Plasmids described in the chapter II, previously constructed for 
quantification of SerRS and LeuRS expression in C. albicans strains. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
pUA563 – Plasmid containing the yEGFP 
reporter system associated with the SES1 
promoter, allowing the determination of 
SerRS expression; used to transform WT and 
TF KO strains with ARG 4 as selective 
marker. 
pUA564 - Plasmid containing the yEGFP 
reporter system associated with the CD60 
promoter, allowing the determination of 
LeuRS expression; used to transform WT and 
TF KO strains with ARG 4 as selective 
marker. 
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A.2 – Plasmids described in the chapter II, previously constructed for 
quantification of Leu misincorporation in C. albicans strains. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
pUA 553 – Plasmid containing the yEGFP 
reporter system with a WT TTA-leucine at 
position 201; URA3 gene is present as a 
selective marker.  
 
pUA 554 – Plasmid containing the yEGFP 
reporter system with a CTG ambiguous codon 
at position 201; URA3 gene is present as a 
selective marker. 
 
pUA 555 – Plasmid containing the yEGFP 
reporter system with a TCT-serine codon at 
position 201; URA3 gene is present as a 
selective marker 
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A.3 – Plasmids described in the chapter II, used for quantification of Leu 
misincorporation in C. albicans strains. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
pUA567 – Plasmid derived from pUA553 
containing an ARG4 gene as selective marker 
inserted between SPEI and NOTI restriction 
sites. 
pUA 568 – Plasmid derived from pUA 554 
containing an ARG4 gene as selective marker 
inserted between SPEI and NOTI restriction 
sites. 
pUA 569 – Plasmid derived from pUA 555 
containing an ARG4 gene as selective marker 
inserted between SPEI and NOTI restriction 
sites. 
